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Abstract
We present the first pipeline to systematically identify and measure
changes in Ψ in alternative splicing events across different genomes
without annotation. Our method identified ~15,000 one-to-one or-
thologous alternative splicing events across human and 4 non-human
primates. We show that alternative splicing events are increasing in
abundance in every human tissue relative to non-human primates.
Additionally, contrary to the tissue-dominated conservation pattern
of gene expression, we show that most tissues except for brain, heart,
and muscle, have a species-specific splicing pattern. Using these or-
thologous events, we identified 3,954 significant differential splicing
events in 1,807 genes between humans and non-human primates. This
thesis represents is part of the ambitious goal towards quantifying
all of the changes in genomic complexity that occur between primate
species. We provide evidence that these changes could be part of the
"missing" genomic basis for the origin of human-specific traits.
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Preface
When alternative splicing was first discovered in 1977, it was considered a unique
phenomenon. Now, with the sequencing of the human genome and many other
genomes, it is evident that alternative splicing is not an exception, it is the rule. Since
the first high-throughput studies of alternative splicing began only ~10 years ago,
being able to study alternative splicing genome-wide is still in its formative years. Even
less studied are the genome-wide changes in alternative splicing across species. Given
the relevance of the non-human primate reference transcriptome resource (NHPRTR),
the largest non-human primate RNA-Seq dataset ever created, new opportunities arose
to enable a timely thesis project to study alternative splicing changes across primates.
Chapter 1 discusses the biologically and bioinformatically relevant background to
the dissertation. Chapter 2 is a description of the richness of the dataset, which has
appeared in Nucleic Acids Research. Some of the computational challenges in creating
isoforms directly from RNA-Seq data is discussed in Chapter 3, which also features
some portions from a manuscript that appeared in Concurrency and Computation Practice
and Experience. Chapters 4 and 5 represent unpublished material regarding the study
and characterization of orthologous alternative splicing events in primates.
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“Change alone is eternal, perpetual, immortal.”
— Arthur Schopenhauer
Chapter 1
Alternative Pre-mRNA Splicing and its
potential for large-scale evolutionary
changes
“Introns are both frozen remnants of history and the sites of future evolu-
tion. . . specific recombinations between introns can bring exons together into
a transcriptional unit to make special differentiation products.”
— Walter Gilbert, Why genes in pieces?, Nature 1978
1.1 Introduction
Alternative splicing, or the production of multiple mRNA variants from a single
gene, is a fundamental regulatory crossroad between transcription and translation
that affects nearly 95% of mammalian genes [1]. In 1978, Walter Gilbert proposed the
now widely accepted notion that the function of alternative splicing is to increase
the diversity of mRNAs expressed from the genome. Gilbert also suggested that
this function has profound implications for evolution since it "can seek new solu-
tions without destroying the old." In 2003, Modrek and Lee observed that exons
that were newly created were prevalent in minor isoforms of a gene which they hy-
pothesized was an evolutionary mechanism to allow the exon to obtain beneficial
mutations without losing the benefits of the major isoform [2]. Only with the recent
advent of high-throughput RNA sequencing (RNA-seq) has alternative splicing on a
1
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transcriptome-wide level been able to be studied with single-nucleotide resolution.
Two timely studies by Barbosa-Morais et al. (2012) and Merkin et al. (2012) both
studying the evolution of alternative splicing in mammalian tissues proposed that the
lack of conservation in alternative splicing events between species may be the driving
force of species divergence. Furthermore, a controversial claim by Barbosa-Morais et
al. (2012) suggested that the highest complexity in alternative splicing occurs within
primates, and that the human cerebellum has more than twice the abundance of alter-
native splicing events than any other tissue studied. It is currently not known how the
cis-acting splicing-regulatory "code" impacts the evolutionary divergence of splicing in
closely related species. The field is at both an ideal and necessary time to understand
the evolutionary changes caused by alternative splicing with a focus on primates [3].
Almost all human protein-coding genes undergo alternative splicing which means
that, depending on cellular conditions, an alternative exon may be included or ex-
cluded from the mature messenger RNA (mRNA). Inside a typical human somatic cell,
on average, 300,000-400,000 distinct mRNA molecules are transcribed from >10,000
genes at a time [4]. The ability to change the output of the genetic information depend-
ing on cellular states, and the ability to greatly increase the proteomic and regulatory
diversity from the information content of the genome, makes alternative splicing a crit-
ical stage for regulating gene expression. The variable use of cis-acting RNA elements
in exons and flanking introns that are recognized by trans-factors allows different pairs
of splice sites in primary transcripts to be selected in a cell type-, condition-, or species-
specific manner. The startling variability and abundance of mRNA transcripts has the
ability to be the source of population-wide complexity in phenotype. In fact, it has
been postulated that even under the simplest genetic systems model of alternatively
spliced transcripts, the production of so many regulatory proteins can cause a cell
to transition into chaos [5]. Although the mechanisms responsible for the regulation
of alternative splicing have been studied in some depth for several genes, only a
limited amount is known about the splicing control factors that function to regulate
alternative splicing genome-wide. Yet, the availability of the genome sequences of
multiple organisms has facilitated tremendous growth in the use of bioinformatics
and genome-wide techniques to study alternative splicing. Although humans may
have roughly the same number of protein-coding genes as C. elegans, alternative
splicing along with other processes such as alternative use of transcription start sites,
alternative polyadenylation, RNA editing, and post-translational modification (i.e.,
phosphorylation, ubiquitylation, and SUMOylation) together expand the proteome
diversity in humans to a staggering level. Alternative splicing is just one process that
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facilitates the extraordinary diversity of the functional landscape. It is still unclear as
to what extent each of these processes contribute to the creation of functionally distinct
proteins but it evident that alternative splicing remains one of the main drivers of this
diversity in eukaryotes.
Because of the ability of alternative splicing to combinatorically create thousands
of isoforms from a single gene, it had been hypothesized since its discovery that
alternative splicing exhibits the capacity needed to account for organismal complexity.
Ever since the first comparative genomics study in 1975 by King and Wilson between
humans and chimpanzees [6], identifying the genetic underpinnings that correlate
with complexity in anatomy and/or behavior has remained elusive. The sequencing of
the human genome and that of model organisms surprisingly revealed that C. elegans
and humans had roughly the same number of protein-coding genes. What exactly
accounts for the vast difference in phenotypic complexity between humans and C.
elegans? Just as one example as a difference in complexity, in the nervous system
alone, humans have several billion neurons while C. elegans has only several hundred.
However, it is clear that the number of appreciable alternatively spliced genes has
greatly increased in humans compared to C. elegans[7] to the point where almost every
gene is alternatively spliced in humans to produce isoforms with different activity,
localization, stability, and/or specificity. Furthermore, alternative splicing is an ideal
candidate to also cause large-scale evolutionary changes. Since the same DNA can
be used to encode multiple different mRNAs, the major-isoform can be produced as
normal while a minor-isoform is altered. The creation of the minor-isoform creates
a tunnel in the fitness landscape that natural selection can then act upon. The most
unique human-specific trait, the brain, has evolved very rapidly over only a few
million years. The complexity of the human brain might be the result of mutations im-
pacting alternative splicing of the many brain-expressed genes instead of incremental
selection on mutations in many different genes. We show evidence in this thesis for
the increased abundance of alternative splicing in brain relative to other tissues and
evidence that the brain is under different selective pressures than other tissues.
1.2 Basics of Alternative Splicing
Precursor messenger RNA (pre-mRNA) splicing was a phenomemnon first dis-
covered 40 years ago that consists of a series of biochemical reactions that function to
remove introns and ligate flanking exons [8, 9]. Alternative splicing occurs within the
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Figure 1.1: Schematic of canonical splice signals.
Figure 1.2: Schematic of the two-step splicing reaction.
context of a multimegadalton ribonucleoprotein complex known as the spliceosome.
The spliceosome is comprised of five small nuclear RNAs (snRNAs) and about 200
protein components. Assembly of the spliceosome on pre-mRNA requires recognition
of several cis-acting splicing-regulatory elements (SREs) located within the intron: the
5’ splice site GU, branch point A, polypyrimidine tract and 3’ splice site AG (Figure
1.1). Within the enormous machine of the spliceosome, intron excision occurs in
two transesterification steps: (1) cleavage at the 5’ splice site (donor site), coupled to
formation of a lariat structure in which the first nucleotide of the intron is linked via a
2’-5’ phosphodiester bond to an intronic adenosine (the branch point) in the vicinity of
the 3’ splice site (acceptor site); and (2) ligation of the two exons, coupled to cleavage
at the 3’ splice site (Figure 1.2). Many diseases are caused by point mutations that
disrupt canonical splice site signals and, in consequence, disrupt the normal splicing
pattern [10]. Splice site recognition is mediated by proteins (serine/arginine proteins,
heterogenous nuclear ribonucleoproteins, polypyrimidine tract-binding proteins, the
TIA1 RNA-binding protein, Fox proteins, Nova proteins, and more) that bind specific
regulatory sequences. Combinatorial control by multiple trans-acting splicing regula-
tors permits specific and differential recognition of short, degenerate signals (exonic
splicing enhancers, ESEs; intronic splicing enhancers, ISEs; exonic splicing silencers,
Alternative Pre-mRNA Splicing and its potential for large-scale evolutionary
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Figure 1.3: Schematic of cis-acting splicing regulatory elements. Silencers are depicted with
bars and enhancers are depicted with arrows. Heterogeneous ribonucleoprotein
particle (hnRNPs) are RNA complexes that bind both exonic splicing silencers
(ESSs) and intronic splicing silencers (ISSs). Serine/arginine (SR) proteins recognize
exonic splicing enhancer (ESE) elements as well as intronic splicing enhancer (ISE)
elements. Polypyrimidine tract binding protein (PTB) is a repressive alternative
splicing regulator. Nova, Fox, and T-cell intracellular antigen 1 (TIA1) are families
of RNA-binding proteins that can either promote or suppress the recognition of the
splice site depending on the position of their binding site.
ESSs; and intronic splicing silencers, ISSs) and creates a situation in which variations
in the concentration of a single trans-factor can elicit a change in the splicing pattern
(Figure 1.3). Cartegni et al. (2002) [11] estimated that up to 50% of all mutations that
lead to gene disfunction are ones that cause aberrant splicing and ∼ 15% of inherited
genetic disorders are caused by deleterious mutations the interfere with splicing. Since
the cost of incorrect splicing to the cell is extremely high [12], the spliceosome has an
intrinsically high degree of fidelity by efficiently pairing constitutively spliced exons
separated by introns up to 105 nucleotides in length [13]. Furthermore, it has been
shown that the recognition of exons by the spliceosome depends equally on signals
from the 3’ and 5’ splice sites [14]. Most regulation of alternative splicing occurs at
the earliest stages of the spliceosome assembly pathway: between the interaction of
cis-acting and trans-acting factors that either promote or repress the recognition of the
canonical splicing signals. While the processing of short introns is thought to be largely
dependent on the proximity of a 5’ and 3’ splice site [15], the processing of long introns
is thought to require more regulatory information such as cis-regulatory motifs and
trans-acting splicing factors, the chromatin landscape, and the kinetics of polymerase
elongation [16–18]. In fact, a survey of the canonical splice signals determined that
the information content in the signal becomes less preserved as the number of introns
increases which leads to insufficiency of correct splicing in higher eukaryotes [19].
Additionally, Sun and Chasin [20] found that in large introns it is possible to identify
many pseudo splice sites that represent canonical signals even closer than the actual
splice sites. This degeneracy creates possibilities for splice site recognition especially
Alternative Pre-mRNA Splicing and its potential for large-scale evolutionary
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Figure 1.4: Schematic of common splicing patterns.
when canonical signals are weak. There are a number of features that impact splice
site choice including exon and flanking intron length, splice site strength, splicing
cis-regulatory elements, interspersed repeat content, mRNA secondary structure, and
RNA editing. Exon shuffling, exonization of intronic sequences, and transition of a
constitutive exon to an alternative exon are the three evolutionary mechanisms known
to create an alternatively spliced exon, and different common types of alternative splic-
ing are shown in Figure 1.4. In humans, exon skipping is by far the most common
type of alternative splicing.
1.3 Identification of alternative splicing events
Starting with customized microarrays, high-throughput technology for the iden-
tification of alternative splicing events has only been around since 2001 [21]. Initial
studies used multi-probe designs of microarrays to detect splicing variants and at-
tempt to quantify their expression. Later studies improved the designs of these probes
to discover novel spliced isoforms of genes and determine the tissue specificity of
alternative splicing events [22–24]. Since next-generation sequencing has become avail-
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able, RNA-Seq quickly became the standard form for studying alternative splicing
genome-wide. RNA-Seq provides a high-throughput way to directly or indirectly
sequence RNA molecules. RNA-Seq has the ability to detect unannotated alternative
splicing events, is not confounded by cross-hybridization like microarrays, can rela-
tively accurately quantify gene expression and percent-spliced in, and can provide
the study of RNA editing and genetic variants with its single nucleotide resolution.
Most RNA-Seq methods initially convert RNA into cDNAs which are made into a
sequencing library consisting of short DNA fragments of the RNA of interest, which
is then flanked by adapters. Next, the DNA library is sequenced from a single-end
or both ends (paired-end) which results in the final pool of RNA-Seq reads. This
results in RNA-Seq reads that represent a snapshot of the expression in a cellular
sample of interest [25]. Yet there are many challenges when using RNA-Seq to study
alternative splicing events. First, different library generation protocols which can
also vary in sample quality, concentration, sequencing depth, and read length create
batch effects that greatly influence the downstream analyses. Second, in order to
study splicing it is desirable to have a large number of splice junction reads, which
means that, in order to be accurate, the RNA-Seq generation can be costly because it
needs to be long-read, paired-end, and at high sequencing depth. Third, the RNA-Seq
reads produced are much shorter than most full-length isoforms, so these must be
computationally reconstructed either de novo or genome-guided, and the accuracy of
this is limited. In general, there are two methods, exon-centric and isoform-centric, to
bioinformatically analyze alternative splicing using RNA-Seq. Exon-centric methods
estimate the frequency of exon inclusion by calculating percent-spliced-in (PSI) against
the global expression of the gene. Isoform-centric methods estimate the abundance
of each isoform but this has large uncertainty for most full-length isoforms. Most
alternative splicing studies with RNA-Seq has relied on gene annotation which has
made studying splicing in unannotated or poorly annotated genomes difficult if not
impossible.
1.4 Comparative primate transcriptomics and evolution
by splicing
To date, there have been few studies that have used comparative RNA sequencing
to study differences among primates. Blekhman et al. (2010) [26] sequenced liver RNA
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in biological triplicate from human, chimpanzee, and rhesus macaque ( ∼ 13 million
35-bp single-end reads per individual), mapped the reads to the respective reference
genomes, and identified frequent lineage-specific changes in transcript expression.
Brawand et al. (2011) [27] performed RNA sequencing on nine mammalian species
including human, chimpanzee, gorilla, orangutan, bonobo, and macaque using cere-
bral cortex, cerebellum, heart, kidney, liver, and testis ( ∼ 25 million reads, some with
100-bp paired-end reads, per tissue per individual). They characterized the extent of
transcriptome variation between organs and species and identified putatively selec-
tively driven expression switches that could have an impact on phenotypic changes
between the species. Perry et al. (2012) [28] characterized genetic and regulatory
primate variation by sequencing liver RNA from 11 NHPs ( ∼ 16.4 million 76-bp paired
end reads per individual) of which 7 of those NHPs had little or no published genomic
resources, and de novo assembled the reads and performed a multispecies alignment.
The Brawand et al. (2011) [27] dataset was later used by Reyes et al. (2013) [29] that
identified 3,800 exons that show strong tissue-dependent usage patterns across all
primate species. These three datasets (Blekhman et al., 2010 [26]; Brawand et al., 2011
[27]; and Perry et al., 2012 [28]) represented the only primate RNA-seq datasets that
were publicly available before this thesis started. Merkin et al. performed RNA-seq on
9 tissues ( ∼ 120 million reads per tissue per individual) from five vertebrates in biologi-
cal triplicate that included rhesus macaque and Barbosa-Morais et al. (2012) performed
RNA-seq from 10 vertebrate species that included human, chimpanzee, orangutan,
and macaque using whole brain, forebrain cortex, cerebellum, heart, skeletal muscle,
liver, kidney, and testis. Evidence from Merkin et al. (2012) and Barbosa-Morais et
al. (2012) both showed that while gene expression patterns across species are highly
conserved, most alternative splicing events are unexpectedly species-specific. Further-
more, they propose that the amount of isoform variability is so high between species
that it may act as a driving force for speciation. The fast rate of evolution in alternative
splicing might be explained by alternative splicing as a mechanism that enables cells
to experiment with new versions of proteins without risking the complete loss of the
original transcript isoforms. These new results are in line with results from Modrek
and Lee (2003) [2] who used EST data to show that most minor splice forms between
mouse and human are not conserved. This evidence supports an evolutionary model
in which alternative splicing can relax negative selection pressure against large-scale
changes in gene structure such as exon creation. There is strong negative selection
against the introduction of a new exon into an existing gene because it is likely to
disrupt the reading frame or disrupt an essential structural or functional element in the
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protein product. However, if a new exon was introduced in a minor splice form, this
would not interfere with the original gene product so the negative selection pressure
against this event would be minimal. Thus, alternative splicing perhaps opens neutral
or nearly neutral evolutionary paths for large-scale evolutionary changes like exon
creation events.
1.5 The splicing code
Alternative splicing also introduces strong selection pressure for RNA-sequence
motifs that are involved in the regulation of alternative splicing. One of the long-term
goals in the splicing field is to decipher the "splicing code" which controls the splicing
pattern of any primary transcript from its sequence in a wide range of cell types and
conditions. Apart from the canonical splice site signals, the majority of the information
required for splicing is thought to lie in the SREs. RNA-seq data has not only allowed
systematic bioinformatic analyses to probe the general validity of known regulatory
sequences but it has also allowed identification of new SREs. One of the most cited
examples of this approach is the analysis of the splicing patterns of over 3,500 cassette-
type alternative exons across 27 mouse tissues (in four different tissue systems: the
central nervous system, muscle, digestive system, and whole embryos) ranging in
development from embryonic stages to adult [1]. Barash et al. (2010) were able to make
genome-wide predictions for different classes of tissue-specific alternative splicing
events by developing a machine learning algorithm that extracted combinations of
SREs (from a compendium of over 1,000 SREs). As previously mentioned, in order
for the spliceosome to reliably differentiate authentic exons and splice sites from
pseudo-exons and decoy splice sites, it relies on specific features of the sequence
such as ISEs, ISSs, ESEs, and ESSs. More specifically, the ESEs are specific short
nucleotide sequences that are targeted by trans-factors such as Serine/Argine-rich
proteins which promote exon definition [30]. ESSs act as binding sites for trans-factors
(such as hnRNP proteins) to help the spliceosome ignore pseudo-exons and decoy
splice sites [31]. The ISEs and ISSs have similar roles and are located in the introns.
While diverse, these splicing factors have some similar characteristics and binding sites
for splicing factors have been identified in long stretches of RNA. For example, binding
sites for polypyrimidine tract-binding protein and CELF proteins are contained in
the polypyrimidine tract [32], binding sites for TIA1/TIAL1 proteins are contained in
poly-U stretches [33], and binding sites for NOVA-1 are contained in clusters of YCAY
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near splice sites of alternatively spliced exons [34]. The preferences for splicing factors
to bind consecutive elements can be partially attributed to the modularity of their
structure which typically contains several RNA recognition motifs that are involved in
binding [35]. Like transcription factor binding sites, clusters of splicing factor binding
sites are evolutionarily conserved. There are currently 71 experimentally validated
(i.e., by CLiP-seq results) human RNA-binding splicing regulatory proteins [36] with
thousands of binding sites. There are many bioinformatics tools publicly available to
study or predict splice signals. They have various approaches from using blastn to
align a query sequence to a database of alternative splicing events and splice signals
(EuSplice from Bhasi et al., 2007 [37]) to ab initio prediction approaches (MHMMotif
from Churbanov et al., 2006 [38]) to a method that considers the splicing factor genomic
environment as wells as evolutionary conservation of the element [39].
1.6 Functional changes associated with splicing changes
The effects of alternative splicing on protein products can be dramatic. For example,
alternative splicing in the gene encoding the Fas receptor produces varying effects on
apoptosis [40], differential constitutive splicing in males and females of the fruitless
gene in Drosophila is essential for courtship behavior [41], and ganglion-specific
splicing of the TRPV1 gene in vampire bats underlies their specialized ability to detect
infrared radiation [42]. A genome-wide view can be taken by analyzing DNA variants
that alter splicing ratios and mapping their traits through splicing quantitative trait
loci (sQTLs). Gonzalez-Porta et al. (2012) [43] estimated that ∼ 60% of total variation
in transcript isoform abundance is due to transcription variation. Thus, the remaining
variability can be largely due to splicing variation. The first genome-wide analyses
of splicing variation were done with the Affymetrix exon array with ∼ 6 million
exon-targeted probes [44–46]. In these studies, the microarray probe intensities of
individual exons relative to those of the entire gene model were used to quantify exon
inclusion levels and then associations with SNPs were tested to identify sQTLs. Kwan
et al. (2008) [44] investigated the alternative splicing variation in lymphoblastoid cell
lines derived from the CEU HapMap population, and identified marker loci linked
to particular alternative splicing events. They detected both annotated and novel
alternatively spliced variants, and showed that such variation among individuals
is heritable and genetically controlled. Heinzen et al. (2008) [47] again used the
same Affymetrix exon array to study tissue-specific alternative splicing in brain and
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blood cell samples and suggested that splicing effects might have more phenotypic
significance than overall changes in gene expression. With the advent of RNA-seq, we
now have the ability to detect novel transcripts that are not probed on the microarray
and can more accurately quantify exon inclusion levels at single nucleotide resolution.
We can also precisely infer the effects of the disruption the splicing signal. For each
exon of each gene, the fraction of reads mapped to that exon compared to all reads in
the gene can be used as a quantitative trait. There are a few pioneering studies that
have characterized transcriptome variation using RNA-seq data. Pickrell et al. (2010)
[48] used low-coverage RNA-seq data from 69 lymphoblastoid cell lines derived from
unrelated Nigerian individuals and performed a linear regression of the relative exon
inclusion levels against all polymorphisms within 200 kb of the gene and found 187
putative sQTLs in humans. Montgomery et al. (2010) [49] also used low-coverage
RNA-seq data (37-bp paired-end sequencing; 11-22 million reads per individual) and
used the exon reads counts as the phenotype and carried out Spearman correlation
analysis with the genotypes.
1.7 Motivation
This study provides the first report of RNA-seq analysis for several primate
species (i.e., Sooty Mangabey, Common Marmoset, Ring-Tailed Lemur, and Pig-tailed
Macaque). This study is also the first attempt known to use >2 billion RNA-seq reads
to build a transcriptome de novo. This is also the most extensive study profiling RNA-
seq expression from 10 different tissues from 12 non-human primates, and we have
already created the most comprehensive transcriptome database for these species.
Since alternative splicing has not been studied in these species extensively, this will
also be the first study to do so with single nucleotide resolution.
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Abstract
RNA-based next-generation sequencing (RNA-Seq) provides a tremen-
dous amount of new information regarding gene and transcript struc-
ture, expression and regulation. This is particularly true for non-
coding RNAs where whole transcriptome analyses have revealed that
the much of the genome is transcribed and that many non-coding tran-
scripts have widespread functionality. However, uniform resources
for raw, cleaned and processed RNA-Seq data are sparse for most
organisms and this is especially true for non-human primates (NHPs).
Here, we describe a large-scale RNA-Seq data and analysis infrastruc-
ture, the NHP reference transcriptome resource (http://nhprtr.org); it
presently hosts data from 12 species of primates, to be expanded to
15 species/subspecies spanning great apes, old world monkeys, new
world monkeys and prosimians. Data are collected for each species us-
ing pools of RNA from comparable tissues. We provide data access in
advance of its deposition at NCBI, as well as browsable tracks of align-
ments against the human genome using the UCSC genome browser.
This resource will continue to host additional RNA-Seq data, align-
ments and assemblies as they are generated over the coming years and
provide a key resource for the annotation of NHP genomes as well
as informing primate studies on evolution, reproduction, infection,
immunity and pharmacology.
2.1 Introduction
Sequencing genomes has quickly become the scientific standard for being able to
study any organism. The rapidly falling costs of sequencing from the development
of massively parallel sequencing technologies have now made it possible for even
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individual laboratories to undertake whole genome efforts at unprecedented reso-
lution and scale [1]. For non-human primates (NHPs), this has resulted in genomic
and transcriptomic information changing from virtually non-existent to becoming
extremely expansive within the last few years [2]. Complete published draft genome
sequences are now available for the chimpanzee [3], gorilla [4], baboon [5] and the
Indian rhesus macaque [6], along with recently completed draft genomes for the
cynomolgus macaque [7] and the Chinese rhesus macaque [8]. With the publication
of each genome has come the increased power to make evolutionary and functional
inferences. However, the annotation of these genomes has often lacked extensive
evidence for the transcriptionally active units, again reflecting the historical high-cost
and labor-intensive effort of cDNA sequencing, a problem affecting the annotation
of both protein coding genes and the newly appreciated non-coding RNAs. The
most recent estimates of the well-annotated human genome show more non-coding
genes than protein coding genes (ENCODE)[9] and research has now confirmed the
role of non-coding RNAs have in pre- and post-transcriptional gene regulation [9],
developmental processes[10] and human disease [11]. However, non-coding genes
have been very limited or absent in the annotation of NHP genomes and like many
protein coding genes they are inferred based on the human genome[12] rather than
from species-specific evidence.
NHPs provide critical biomedical models for many aspects of human health and dis-
ease and yet the genetic basis of phenotypic traits in NHPs remains poorly understood—
despite the amount of genomic data now available. Therefore, the full potential of
these model organisms can only be realized with a complement of genomic informa-
tion that captures both the similarities and differences to human, a requirement that
is equally critical to understanding primate evolution. Most notably, comparative
genomics studies strongly suggest that the significant differences between modern
humans and chimpanzees are likely due at least as much to changes in gene regulation
as to modifications of the genes themselves, a conjecture initially proposed by King
and Wilson >30 years ago [13] and reinforced by the ENCODE results that suggest
functional/regulatory roles for much of the genome that is devoid of protein coding
loci.
Following the 4th International Conference on Primate Genomics (Seattle, 2010),
we organized a committee of investigators to assess the requirements of the research
community for NHP transcriptome information; this process included representatives
from many of the National Primate Research Centers, as well as experts in primate
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Figure 2.1: Species of the NHPRTR. Animals were chosen to represent large evolutionary
distances, encompassing hominoid, Old World and New World Monkeys and
prosimians. Two geographic subspecies were included for each of the following
species: rhesus macaques (Indian-origin and Chinese-origin) and cynomolgus
macaques (Mauritian-origin and Indonesian-origin).
evolution from other research organizations. Based on these discussions, 13 species
of NHPs were chosen for transcriptome characterization (Figure 2.1), with selection
emphasizing their use in important biomedical models, evolutionary diversity and the
status of genome sequencing. The particular importance of NHP models for studies of
AIDS pathogenesis and vaccines, respiratory disease models, metabolic disorders and
neurobiology led to the inclusion of multiple Macaca species, as well as geographic
subspecies for the rhesus macaque and the cynomolgus macaque due to phenotypic
differences noted for these regional variants. For these 15 species/subspecies, the goal
for the initial sequencing effort was to capture a maximum diversity of transcripts
for any one species, thereby providing a breadth of evidence for annotating transcrip-
tionally active regions (TARs) of the respective genomes. To accomplish this, a list of
21 relevant tissues was determined that covered the range of physical and functional
compartments of the animals (cf. Figure 2.2) and then a centrally coordinated effort
was undertaken to obtain the tissues from various institutions (see ’Materials and
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Methods’ section; contributing institutions are listed in ’Acknowledgments’ section).
For each species, RNA was isolated from the available tissues (with the exclusion of
blood samples) and equal masses of RNA were combined to prepare the reference RNA
sample that was used to generate the sequence data. (Blood RNA was not included in
the general RNA composite due to the high abundance of hemoglobin RNA in such
samples; therefore blood RNA will be the subject of a separate sequencing effort.) To
improve functional genomics annotation for NHPs, we employed multiple methods of
library preparation [14, 15], thereby generating RNA-based next-generation sequenc-
ing (RNA-Seq) data characterizing coding and non-coding transcripts, delineating
information on strand-specificity and enabling accurate detection of antisense tran-
scription (Figure 2.2). We have named this effort the ’NHP reference transcriptome
resource’ (NHPRTR; online at: http://nhprtr.org), intending it to provide the com-
munity with the sequence data from the composite RNA samples and with access
to derived results (processed reads, alignments, assemblies) as these become avail-
able from our own efforts as well as from others who are contributing to this central
resource. Though some limited amount of NHP transcriptomic data exists [16, 17],
no studies or databases exist across both a large number of species and tissues, thus
making the NHPRTR the most comprehensive database of primate transcriptomic
information that is publicly available. Importantly, the NHPRTR is directly linked to
our sample bank resource and we can provide purified RNA for the individual tissues
from the species included in the resource, depending on availability.
2.2 Results
2.2.1 Summary of primary and processed data
Our current data set contains 40.5 billion 100 nt reads from 21 tissues across
13 primate organisms (Table 2.1), with the majority of our data coming from 100
× 100 paired-end (PE) reads from the Illumina HiSeq2000. From the home page
at http://nhprtr.org (Figure 2.3), our resource site is designed to provide easy
access to many resources, including pages that describe the overall goals of the
project, its current status, contact information, external links and also the link to
the data page. The data page hosts all of the raw data from the sequencing of the
various species and each of their library preparations, with a file name that repre-
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Figure 2.2: Tissue sources and methods for library construction and sequencing. (Top) The
tissues being sequenced (top) cover 21 regions that focus on the brain, immunolog-
ical and sexual tissues as well as general tissues important for pharmacogenomics.
The majority of the individual tissues will eventually be sequenced as individual
libraries to examine tissue-specific expression patterns. (Middle) Three different
biochemical techniques were used for preparing cDNA libraries to enable the broad-
est examination of the transcriptome for each species. We used an RNA-ligation
method for all RNA species (Total RNA-Seq), poly-A enriched cDNA synthesis
(mRNA-Seq) and another version of mRNA-Seq that maintained the Watson or
Crick strand of origin for the transcript by using dUNTPs during second strand
synthesis (UDG). (Bottom) All cDNA libraries were then subjected to a DNA nor-
malization step using Duplex-specific nuclease treatment, and then all samples
were clustered, sequenced, and processed using standard Illumina methods and
materials, generating 41 billion reads.
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Table 2.1: Summary of current data in NHPRTR. The 40.5 billion reads span three differ-
ent library preparation methods and two sequencing instruments (GAIIx and the
HiSeq2000)
Species
File size
(GB)
HiSeq2000 (2 × 100 nt paired-end reads) GAII (100 nt single-end reads)
Protocol
Number of
read pairs
Protocol Number of reads
Baboon 973
mRNA-seq 955,573,799 mRNA-seq 71,477,607
UDG
mRNA-seq
918,735,897
UDG
mRNA-seq
67,763,503
Total
RNA-seq
151,524,634
Chimpanzee
94.9
Total
RNA-seq
198,954,000
399.1
UDG
mRNA-seq
836,864,082
Cynomolgus Macaque
Indochinese
948
mRNA-seq 923,307,160 mRNA-seq 72,016,960
UDG
mRNA-seq
894,367,594
UDG
mRNA-seq
63,820,198
Cynomolgus Macaque
Mauritian
656 Total RNA-seq 206,526,535
422.6
UDG
mRNA-seq
886,261,413
Japanese Macaque 986
mRNA-seq 942,269,530 mRNA-seq 77,740,433
UDG
mRNA-seq
943,158,996
UDG
mRNA-seq
72,925,864
Total RNA-seq 181,184,542
Marmoset
128.8 Total RNA-seq 269,969,905
418.9 UDG mRNA-seq 878,369,246
Mouse Lemur
97.5 Total RNA-seq 204,494,231
378.9 UDG mRNA-seq 794,659,816
Pig-tailed
Macaque
951
mRNA-seq 867,009,248 mRNA-seq 54,292,043
UDG mRNA-seq 991,993,458 UDG mRNA-seq 54,668,320
Total RNA-seq 131,548,564
Rhesus Macaque
Chinese
700
mRNA-seq 644,468,744 mRNA-seq 77,142,089
UDG mRNA-seq 661,177,666
UDG mRNA-seq 75,142,089
Total RNA-seq 121,570,595
Rhesus Macaque
Indian
1331.2
mRNA-seq 1,716,083,364 mRNA-seq 84,892,037
UDG mRNA-seq 704,493,397
UDG mRNA-seq 70,346,332
Total RNA-seq 168,710,995
Ring-tailed
Lemur
104.8 Total RNA-seq 219,647,886
398.7 UDG mRNA-seq 835,972,568
Sooty Mangabey
106 Total RNA-seq 222,192,568
424.4 UDG mRNA-seq 889,864,522
Total 9618.3 18,667,116,290 2,112,066,539
Total number of reads 39,446,299,119
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Alignments	
(.bam/.bed/.bigwig)	
STAR
De	novo	assemblies	(.fasta/.bed/.psl)	
Trinity
Raw	Data	(.fastq.gz)
Cleaned	Data	(.fastq.gz)About Project
Status
Links Contact
Data
md5sums
Figure 2.3: Organization of the NHPRTR. We have designed our database and the interface
page to give users a clear sense of the goals, organization and data types present.
Pages include the project background (about.html), the latest updates (status.html),
connections to other sites (links.html), contact information (contact.html) and the
data from the NHPRTR (data.html, including md5sums). From the data page (mid-
dle), users can access the raw data or various forms of the processed data, including
cleaned data (hosted on NCBI’s Sequence Read Archive), alignments (using STAR)
and assemblies (Trinity). The alignments and assemblies can be viewed on our
UCSC Genome Browser Mirror (http://lp364.genome-mirror.cshl.edu). The data
page will continually update as data are submitted and as work is completed.
sents the provenances of the data generation. For example, the PE reads sequences
from the Baboon UDG library called ’HCT20960’ sequenced on lane five, appear as
BAB_UDG_HCT20960_L005_R1.fastq.gz and BAB_UDG_HCT20960_L005_R2.fastq.gz.
Finally, under each set of data, we have posted md5sums of each of the files, so users
can readily confirm their accurate receipt of the data after download.
Our primary data analysis and quality checking have shown that our data are
of very high quality (Figures 2.4 and 2.5), with a median Quality Score (Q-score)
consistently >34 (>99.95% accuracy) across the length of the reads. Also, we used the
tool Stitch [18] to check the overlap of the reads and found that the insert size of the
cDNA libraries were within the expected range of 140-160 bp, since the mode of the
distribution of the overlap of the PE (100 × 100) libraries was near 40-60 (Figure 2.6).
Finally, the data distribution page also provides the output files from the FASTQC
toolkit, to allow a deeper examination of the read statistics and qualities [19].
Once a species is sequenced and quality checked, the NHPRTR site also hosts a
second version of the primary data. This second set is a ’cleaned version’ which is
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Figure 2.4: High accuracy base-calling across the length of the read. We used boxplots to show
the distribution of quality scores from base 1-100, and we consistency observe base-
calling accuracy above Q30 (>99.9%), with the median never falling below Q34 for
the 1x100 runs on the GAIIX and the 2x100 runs on the HiSeq2000 . Representative
plot is shown from library HCT20763 after read cleaning.
Figure 2.5: Quality plot is from library HCT20763 before read cleaning.
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Figure 2.6: Bioinformatic confirmation of the estimated cDNA insert size. We used the program
Stitch to estimate the overlap of bases for the 100x100 PE libraries, and we observed
overlaps on average of 40-60bp, which confirms the expected insert size from the
Agilent Bioanalyzer 2100 (140-160bp) on libraries 20763 and 20764.
generated for use in algorithms that are especially sensitive to sequence errors, such
as de novo transcript assemblers and genome assemblers (Figure 2.7). We first trim
all reads for low quality (<Q20), remove any remaining adapter sequences and any
lengthy polyA/T stretches (>6 homopolymers) using Flexbar, in order to eliminate
bad quality reads and the sequences from the ends of polyA tails or low complexity
regions. We then align all reads to the known primate sequences for mtDNA and
rRNA and exported these to a separate alignment files. We found that these steps
remove between 3% and 10% of the data. These files can save significant time for
researchers who want to begin with even higher quality data and who do not wish to
focus on the mitochondrial or ribosomal sequences.
2.2.2 Alignments and data visualization
As the gene models for each species improve, it is often useful to gauge the state
of these emerging data in relation to the best defined gene annotation set available–
the human genome. To enable such work, the NHPRTR hosts an alignment to the
human genome (hg19 and hg18) using Burrows-Wheeler Aligner (BWA) [20] and
can all be readily viewed within the UCSC genome browser from a direct link on
http://nhprtr.org. While we recognize that using the human genome as an alignment
reference for distant phylogenetic species is not ideal, we still provide these alignments
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Figure 2.7: Pipelines for de novo transcript assembly. We used Trinity to test the utility of
these data for de novo assemblers using 50M reads. We used our cleaning pipeline
(methods) to filter the reads, and then we ran the three main steps of Trinity
(Inchworm, Chrysalis, Butterfly), which required 120GB of RAM for a dataset
of only 50M reads. These results highlighted the need to migrate these data to
large-scale computing resources.
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for several reasons. First, the human genome is the best annotated genome across
primates and it hosts a wealth of other regulatory and functional data linked to the
genomic coordinates. Second, the data can already be useful as a comparison of gene
structures in expressed areas, placing genes in syntenic blocks and helping to define
orthologous gene sets. Third, some species in the NHPRTR database have no genome
yet sequenced. Finally, even though sequence divergence will decrease mapping rates,
the alignments still provide a basic orthologous expression map across all species.
We observed that these human alignment data generated several immediate results.
First, users can browse to any given human gene of interest and gauge the gene
structure and rough expression level of that gene. Second, any hypothesized changes in
gene structure, such as shortening, lengthening or splicing changes, can be visualized
and compared to human structures. Third, the differences in the types of RNA-Seq can
readily show the benefit of using multiple biochemical methods for the examination
of a transcriptome (Figure 2.8). For instance, the detection of non-poly-adenylated
transcipts such as snoRNAs or some histones can be readily seen in the Total RNA
prep, whereas they are missing from the two mRNA preps.
2.2.3 Ongoing database work and analysis plans
As described here, this large-scale, EST-like resource of 13 species/subspecies of
NHPs across 21 tissues is immensely useful for primate researchers, evolutionary
biologists, immunologists and neurobiologists. With the addition of the Squirrel
Monkey, Owl Monkey and other tissue-specific sequencing, we anticipate having
~100 billion reads from 15 primates when sequencing is completed in 2013. We
plan to sequence individual tissues from the Indian-origin rhesus macaque from
animals at different stages following SIV infection and also perform tissue-specific
sequencing using different cDNA methods. Taken together, these data will create an
unprecedented depth of expression and single-base resolution expression data for
all of these species’ tissues. Most significantly, the different types of biochemistries
utilized for cDNA synthesis and RNA preparation for sequencing will create a broad,
comprehensive profile (polyA and total RNA) of the transcriptome for each tissue
and each species. Several ongoing analysis efforts from these data will be posted to
the NHPRTR site, leveraging a variety of aligners and assemblers. First, as relevant
published work in NHP transcriptomes appear [21], we will link to them on our site.
Next, additional alignments from the AceView aligner [22] will be added, which will
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Figure 2.8: Browsable tracks. (A) We used BWA aligner to create cross-species maps of expres-
sion, based on the alignment to orthologous sequences of the human genome. Here
we show the three library preparation methods (TOT, UDG, RNA), with one in
each track for seven species. (B) The insert shows how the Total RNA preparation
method (middle expression track) can more readily discern non-poly-adenylated
genes, such as the histone genes.
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Figure 2.9: Web Statistics for NHPRTR Data Download Page. We used the webalizer (v2.01)
program (http://www.webalizer.org/) to generate statistics about the site’s down-
load rates of the raw and processed data. We observed an increasing rate of hits
and data downloads over the last year.
be very useful for defining the non-coding RNAs of the transcriptome and also the
exon-intron junctions, along with the outputs from Tophat and BWA. We will also host
the results of several de novo transcriptome assemblies as they are completed, based
on the different libraries and available PE and single-end reads as described earlier.
At time of submission, we are hosting preliminary de novo assembly results for the
Mauritian cynomolgus macaque from pilot studies using Oases [23], TransAbyss [24]
and Trinity [25], performed with subsets of the data (cf. Data under http://nhprtr.org).
These assemblies are also linked to the reference genome for each species for species-
specific browsing. Notably, our early efforts revealed that the construction of the de
novo transcriptome assemblies can be a very memory-intensive process (Figure 2.7),
which often required hundreds of gigabytes RAM. Thus, in an effort to help researchers
utilize these data in large-scale computing environments, we are also hosting these
data on the Blacklight 32TB memory node (blacklight.psc.teragrid.org) on the Extreme
Science and Engineering Discovery Environment (XSEDE). We anticipate that having
various means of accessing the primary, processed and assembled reads in multiple
environments will ensure the broadest utilization of these data. In summary, we have
designed the NHPRTR site to utilize familiar tools and formats from the genomics
community and the combination of several library preparations and bioinformatic
tools in the same resource have already created thousands of requests to examine
and download these data (Figures 2.9 and 2.10). We encourage the use of the
data by the community and will assist investigators in hosting their results if they
wish to contribute to the resource and in reciprocity, we also have a section with links
to data from other published primate RNA-Seq studies. Moreover, a main goal in
The non-human primate reference transcriptome resource (NHPRTR) for
comparative functional genomics 30
Figure 2.10: Web Statistics for NHPRTR Data Download Page. We observed traffic coming
from sites in the United Kingdom (UK), U.S. educational sites, commercial sites
(.com), and generate network sites (.net), as well as some unresolved IP addresses
(11%).
generating these data was to provide a rich resource for species-specific alignment,
thereby generating improved gene models for NHP genomes and this is realized by
own ongoing efforts as well the gene annotation and prediction pipelines at ENSEMBL
(B. Aken, personal communication). These data will also be helpful in answering a
variety of questions pertaining to the complexity of transcriptome, including: new
TARs, conservation/evolution of specific splicing sites, RNA editing events, UTR
structures, and gene boundaries and content. In summary, the NHPRTR represents an
immensely useful and timely addition to the genome sequences of these important
species, a key hub for these species’ RNAs and their matching transcriptomic data and
an invaluable resource for genomes that will eventually be sequenced.
2.3 Materials and Methods
2.3.1 Tissue samples
Source tissues for the resource were generally obtained from animals that were
being euthanized either for compassionate reasons due to failing health or as part
of an existing research protocol; all veterinary procedures were approved under
the local Institutional Animal Care and Use Committee (IACUC). Tissue specimens
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were preserved in RNAlater®(Life Technologies) at the time of collection and frozen
at −80◦C. Tissues for gorilla, mouse lemur and ringtail lemur derived from frozen
specimens previously collected at the time the individual animals were euthanized;
these tissues were either transferred into RNAlater or homogenized in TRIzol® Reagent
(Life Technologies) and frozen at −80◦C. All frozen samples were shipped to the
University of Washington and the RNA isolated under a standard protocol using
TRIzol extraction and purification with RNeasy® columns (QIAGEN). Isolated RNA
was characterized by absorbance spectroscopy to ensure the absence of contamination
by protein or phenol and then analyzed by capillary electrophoresis to furnish an
RNA Integrity Number (RIN) using an Agilent Bioanalyzer®. RNA concentrations for
individual tissue RNA samples were based on integrated fluorescence intensity in the
Bioanalyzer runs, calibrated against an RNA standard. For a species or subspecies, the
reference sample combined equal masses of RNA from all the tissues. The number
of available tissues varied among the species; whenever possible tissues were used
from a single female individual and only was obtained from a second individual
(Figure 2.11). The final composition of each reference sample as well as the RIN
value for the individual tissue RNA components is available at the resource website
(http://nhprtr.org).
2.3.2 Library preparations
Three different types of sequencing libraries were prepared from the reference
samples. These were as follows: (i) non-directional mRNA-Seq, (ii) directional mRNA-
Seq based on dUTP strand-marking and (iii) directional Total RNA-Seq, based on
RNA-ligation to the initial RNA fragments which preserves their strandedness. In
all the cases, the initial cDNA library was ’normalized’ using a Duplex-Specific Nu-
clease Protocol (DSN) which removes high-abundance transcripts such as ribosomal
molecules that would otherwise dominate the reads from the Total RNA-Seq libraries.
The majority of sequencing for all species was done on the Illumina HiSeq2000 at
Illumina or Weill Cornell Medical College (WCMC), with additional GAIIx sequencing
performed at Illumina.
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Supplemental Table 1.  Listing of species and summary of tissues used to prepare the RNA pools used for the described RNAseq measurements.  For each species equal 
masses of the purified tissue RNA samples were combined to generate the composite RNA pool that was used for both mRNAseq and total RNAseq.   
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Papio anubis Baboon X X X X X  X X X X X X X X X X X Y X X
Pan troglodytes Chimpanzee X X X X X X X X X X X X X X X X X X X
Macaca fasicularis
Cynomolgus Macaque 
Indochinese X X X X X X X X X X X X X X X Y X X
Macaca fasicularis
Cynomolgus Macaque 
Mauritian X X X X X X X X X X X X X X X Y X X
Gorilla gorilla gorilla Gorilla X X' X' X X' X X X X' X' X X
Macaca fuscata Japanese Macaque X X X X  X X X X X X X X X X X Y X X
Callithrix jacchus Marmoset X X X X X X X X X X X X X X X
Microcebus murinus Mouse Lemur (gray) Y Y Y Y Y Y Y Y Y Y Y Y
Aotus vociferans Owl Monkey X X X X X X X X X X X X X X X X X X X
Macaca nemistrina Pig-tailed Macaque X X X X X X X X X X X X X X X X Y X X
Macaca mulatta
Rhesus Macaque 
Chinese X X X X X X X X X X X X' X X X Y X X
Macaca mulatta
Rhesus Macaque 
Indian X X X X X X X X X X X X' X X X Y X X
Lemur catta Ringtail Lemur X X X X X X Y Y Y Y Y Y X
Cercocebus atys Sooty Mangabey Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y
Saimiri boliviensis 
boliviensis Squirrel Monkey X X X X X X X X X X X X X X X X X X
"X" or "Y" in cell respectively indicate if donor animal was female or male.  Additional donors are indicated 
by prime superscript.  
All tissues were obtained from either tissue distribtuion programs of National Primate Research Centers 
or were pre-existing archival samples from research institutions.   
Tissue specimens were preserved in RNAlater or had been previously homogenized in Trizol, and stored 
at -80˚C until the RNA was purified.  
Figure 2.11: Listing of species and summary of tissues used to prepare the RNA pools used
for the described RNA-Seq measurements. For each species equal masses of the
purified tissue RNA samples were combined to generate the composite RNA pool
that was used for both mRNAseq and total RNAseq. "X" or "Y" in cell respectively
indicate if donor animal was female or male. Additional donors are indicated
by prime superscript. All tissues were obtained from either tissue distribution
programs of National Primate Research Centers or were pre-existing archival
samples from research institutions. Tissue specimens were preserved in RNAlater
or had been previously homogenized in Trizol, and stored at -80◦C until the RNA
was purified.
The non-human primate reference transcriptome resource (NHPRTR) for
comparative functional genomics 33
2.3.3 Standard mRNA-Seq protocol
The standard mRNA-Seq library preparations were done using established Illumina
methods for mRNA-Seq (Part #RS-100-0801). Briefly, poly A+ RNA is purified from 100
ng of total RNA with oligo-dT beads. Purified mRNA is then fragmented with divalent
cations at elevated temperature. First strand cDNA synthesis is performed with
random hexamer priming and reverse transcriptase. Second strand cDNA synthesis
is performed using RNAseH and DNA PolI. Following cDNA synthesis, the double
stranded products are end repaired, followed by addition of a single ’A’ base and then
ligation of the Illumina PE adaptors. For this study, the ligation products were purified
using gel electrophoresis. The target size range for these libraries was ~250 bp on the
gel such that the final library for sequencing would have cDNA inserts with sizes of
~150 bp long. Following gel purification the adapter ligated cDNA is then amplified
with 15 cycles of PCR. This initial library was then subject to DSN normalization and
additional rounds of PCR as described below for the Total RNA-Seq protocol.
2.3.4 Directional (UDG) mRNA-Seq protocol
The directional mRNA-Seq library preparations were done using the variant offered
by Illumina (Part # RS-122-2303). Briefly, poly A+ RNA is purified from 100 ng of
total RNA with oligo-dT beads. Purified mRNA is then fragmented with divalent
cations under elevated temperature. First strand cDNA synthesis is performed with
random hexamer primers and reverse transcriptase. Second strand cDNA synthesis
is performed using RNAseH, dATP, dCTP, dGTP, dUTP and DNA PolI. Following
cDNA synthesis, the products are end repaired, a single ’A’ base is added and then
the Illumina PE adaptors are ligated on to the cDNA products. The libraries are
then amplified with 15 cycles of PCR as before, except in this case the strands that
contain dUMP do not amplify and thus the products of the PCR process retain the
original strand information. For this study, the ligation products were purified using
gel electrophoresis. The target size range for these libraries was ~300 bp on the gel
such that the final library for sequencing would have cDNA inserts with sizes of ~200
bp long. This initial library was then subject to DSN normalization and additional
rounds of PCR as described below for the Total RNA-Seq protocol.
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2.3.5 RNA-ligation-based directional total RNA-Seq protocol with
DSN
The directional Total RNA library is constructed with a modified version of the
Illumina directional mRNA-Seq sample preparation protocol, however no poly-A se-
lection is used in a Total RNA-Seq prep. Briefly, 100 ng of total RNA is fragmented with
divalent cations under elevated temperature. The ends of the fragmented RNA are
treated with phosphatase to remove all 5’- and 3’-phosphate groups, followed by mod-
ification with polynucleotide kinase. This process insures that every RNA molecule
contains a 5’-mono-phosphate group and a 3’-hydroxyl group. A pre-adenylated oligo
is then ligated to the 3’-end of these RNA fragments, followed by the ligation of an
RNA oligo to the 5’-end of the RNA. Following ligation of these adapter oligos, the
RNA is reverse transcribed and amplified with 15 cycles of PCR to create the initial
RNA-Seq library. Ribosomal RNA depletion from the initial RNA-Seq library is carried
out following Illumina’s published protocol. Briefly, 100 ng of amplified PCR products
are denatured at 94◦C for 5 min in 1× hybridization buffer (50 mM HEPES, 0.5 M
NaCl) followed by incubation at 68◦C for 5 h; then 2 U of the DSN Enzyme (available
from Evrogen) is added at 68◦C for 25 min to digest double stranded DNA. Following
DSN digestion the remaining undigested, single-stranded molecules are enriched with
15 more cycles of PCR.
2.3.6 Alignment methods
We used several alignments strategies on the data, with an initial focus on the
alignment of the various species on the human genome. For an extremely conservative
view of cross-species mapping, we used the BWA [20] and removed any sub-optimal
matches (X0==1) and also removed any reads that were one edit distance away from
mapping somewhere else in the genome (X1==0) field. These parameters reduced
issues with paralogs and segmental duplications. For a broader alignment method,
we used the AceView Magic aligner [22] and Tophat [26] (default settings) to generate
mapping rates for each library of each species. The Magic AceView aligner uses
a compressed data format for rapid processing and then uses a seed-and-extend
algorithm based on sequence complexity, boundary detection for splicing, a scoring
matrix for alignment and a mapping hierarchy to assign the reads to the most likely
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location in the genome. Specific bash commands and shell scripts that were used in
the analysis are posted online at nhprtr.org and also in Supplementary Data.
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Chapter 3
Building primate annotations de novo
and their processing
The annotations available for non-human primate genomes are extremely poor
in comparison to the human genome. For example, there are only 72 refSeq genes
for gorilla. In addition to this, the genome build quality for non-human primates is
extremely variable. In some species (i.e., rhesus macaque), the genome is well built
(and now in its 8th version) because of the wide-spread use of rhesus macaques as an
animal model for disease testing. However, in other species (i.e., squirrel monkey) the
genome is completely in scaffolds. Additionally, for another species in our dataset
(i.e, ring-tailed lemur), the nearest genome diverged >20 million years ago. Thus, in
order to comparatively study the alternative splicing changes between species, we
decided to build transcripts by de novo assembly. Our objectives were to create the
most accurate de novo assembly possible with the most efficiency (time and space)
and as few computational service units (cores × compute hours) as possible. We find
that the best transcriptome assemblies are the result of the most input reads and are
assembled without normalization. This chapter describes the pipeline for creating
transcripts de novo and their accuracy. It describes our collaboration with XSEDE and
using the Trinity software on supercomputers for billions of RNA-Seq reads as input.
Portions of this chapter appears in Cougar et al. (2013).
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3.1 Testing for the best quality de novo assembly
De novo assembly of RNA-Seq with Trinity with billions of reads require the use
of computational resources that are beyond the capability of most research groups.
Therefore, Trinity has made available an in silico normalization method, which has
now become the default version of Trinity. In silico normalization greatly reduces
the number of input reads for Trinity by probabilistically selecting reads based on
median k-mer coverage value and targeted maximum coverage value. Developers of
Trinity showed that normalization with just 10 million reads reconstructed full-length
transcripts in S. pombe [1]. Since our dataset was on the order of 10× greater than that
dataset used by Haas et al. (2013), we wanted to test whether in silico normalization
would be similar or improve our assemblies. We have found that although in silico
normalization greatly reduces runtime by >200× , the assemblies produced are not
of the same quality as non-normalized assemblies. We compared assemblies built
by normalization and non-normalization using the same 3.2 billion RNA-Seq reads
from chimpanzee. Table 3.1 shows the general statistics of the two assemblies. The
Table 3.1: Normalized vs. Non-normalized Trinity assembly statistics
Non-normalized Normalized
Total length of sequence 2,012,120,424 1,941,765,648
Total number of se-
quences
2,571,000 2,999,946
Longest transcript 33,952 36,038
N25 3,201 3,362
N50 1,350 1,564
N75 532 599
Total GC count 866,045,003 823,920,621
GC% 43.04% 43,43%
summary statistics of the normalized and non-normalized assemblies are similar.
In fact, the normalized assembly even has a higher N25, N50, and N75 than the
non-normalized assembly. However, the normalized assembly has almost 500,000
more transcripts than the non-normalized assembly, but has a smaller total length of
sequence. It is more helpful to identify what is actually being assembled to assess
the quality of the assemblies. Figure 3.1 shows what parts of the genes are being
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Figure 3.1: Comparison of contig coverage of the gene body with chimpanzee refGene annota-
tion between Trinity assembly built with digital normalization and without. Phase
I is the NHPRTR Phase I data, which includes the pooled RNA-Seq described in
Chapter 2. Phase I + Phase II is the NHPRTR Phase I data and the NHPRTR Phase
II tissue-specific RNA-Seq data. In silico normalization was performed on the Phase
I and Phase II data.
assembled in normalized vs. non-normalized assemblies and Figure 3.2 shows what
fraction of genes are being fully assembled. We show the de novo assembly built with
only Phase I data for scale. These results indicate a dramatic difference in the
quality of the assembles being produced by each method. It shows that the normalized
assembly is only able to assemble the beginning of the gene (starts to deviate from
the non-normalized assembly halfway through the gene), and does a very poor job of
assembling the end of the transcript. Additionally, the non-normalized assembly with
Phase I and II data is able to recover the most full-length transcripts, which is important
for identifying novel isoforms and accurate splice junctions. Adding the Phase II data
results in a big improvement in the number of additional genes assembled. Thus,
even though the normalization method greatly reduces the computational burden and
runtime, we declined to use the in silico normalization method since we wanted to
identify as many splice junctions as possible in all parts of the gene. Although the
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Figure 3.2: Comparison of fraction of Chimpanzee refGene assembled between Trinity assem-
bly built with digital normalization and without. Trinity assemblies were aligned to
panTro5 and fraction of refGene assembled was calculated by how much the contig
overlapped with the refGene. Phase I is the NHPRTR Phase I data, which includes
pooled RNA-Seq described in Chapter 2. Phase I + Phase II is the NHPRTR Phase I
data and the NHPRTR Phase II tissue-specific RNA-Seq data. In silico normalization
was performed on the Phase I and Phase II data
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non-normalized method can take months at a time to assemble, we though it was
necessary to produce accurate full-length transcripts in order to identify orthologous
splicing events. The rest of this chapter discusses the building of de novo transcripts
with Extreme Science and Engineering Discovery Environment (XSEDE) resources.
3.2 Enabling large-scale next-generation sequence
assembly with Blacklight
A variety of extremely challenging biological sequence analyses were conducted
on the XSEDE large shared memory resource Blacklight, using current bioinformatics
tools and encompassing a wide range of scientific applications. These include genomic
sequence assembly, very large metagenomic sequence assembly, transcriptome assem-
bly, and sequencing error correction. The data sets used in these analyses included
uncategorized fungal species, reference microbial data, very large soil and human gut
microbiome sequence data, and primate transcriptomes, composed of both short-read
and long-read sequence data. A new parallel command execution program was de-
veloped on the Blacklight resource to handle some of these analyses. These results,
initially reported previously at XSEDE13 and expanded here, represent significant
advances for their respective scientific communities. The breadth and depth of the
results achieved demonstrate the ease of use, versatility, and unique capabilities of
the Blacklight XSEDE resource for scientific analysis of genomic and transcriptomic
sequence data, and the power of these resources, together with XSEDE support, in
meeting the most challenging scientific problems. High-throughput, next-generation
sequencing (NGS) of genomes [2, 3], transcriptomes [4], and epigenomes is currently in
a phase of burgeoning growth with each passing development cycle yielding a greater
than exponential return in the amount of quality sequence data generated per unit of
cost (www.genome.gov/sequencingcosts). This rapid progress in data generation can
currently create data sets within weeks, which are computationally intractable [5] for
complete scientific analysis because of the large RAM footprint required or the volume
of data to be analyzed. This limits their potential use in areas of scientific interest [6]
and in translational medicine [7, 8].
The computational requirements of these data sets often exceed the capacity of
personal computing systems, server-level infrastructure, distributed high performance
computing, and large shared memory high performance computing systems. Hence,
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many important scientific questions for which the data are or could be available either
go unanswered or can only be addressed by a few research groups with a large bioin-
formatics infrastructure. Here we present science outcomes that highlight the ability
of the cache coherent non-uniform memory access architecture of the XSEDE resource
Blacklight, housed at the Pittsburgh Supercomputing Center (PSC), to allow efficient
genomic analysis of data sets outside the scope of other high performance computing
systems, as well as user-friendly high-throughput analysis of standard-sized to large-
sized genomic data [9]. With these complementary capabilities, the XSEDE resource
Blacklight extends the current technical limits of genomic and transcriptomic assembly
for analyses requiring the largest shared memory systems, as well as the scope of
genomic research by enabling high-throughput large shared memory analysis.
3.2.1 Blacklight
The Blacklight system at the PSC is an SGI Altix UV 1000 (SGI (Silicon Graphics,
Inc.), Milpitas, CA 95035, USA) with two partitions, each containing 16 TB of cache
coherent shared memory and 2048 cores. This means that a single application running
on Blacklight can access up to 16 TB of shared memory using up to ~2000 cores. The
obvious application of this system is for algorithms and problems that benefit from
holding large amounts of data in RAM. However, the fast interconnect that facilitates
cache coherent non-uniform memory access across the system also enables rapid com-
munication within distributed memory applications. This dual nature of the system
allows researchers to run problems across a continuum, from a single, massive shared
memory application to many large shared memory applications running in parallel
to fully distributed or embarrassingly parallel applications. Because the realm of
genomic analysis encompasses all of these modes of computing, this flexibility makes
Blacklight convenient and powerful for researchers dealing with diverse genomic anal-
ysis pipelines. In addition, because Blacklight is essentially one big system, running
a single operating system, it is ideal for rapid prototyping of new serial and parallel
algorithms for large data analysis.
3.2.2 Data generation with massive RNA-seq
In 2010, a committee of researchers set out to create a non-human primate reference
transcriptome resource (NHPRTR) to help establish the genetic basis for phenotypic
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differences observed between primates, including differences between humans and
non-human primates (NHPs). Such a resource can provide valuable information
regarding evolutionary processes, as well as insight into human health and disease
from the pharmacogenomics work performed on the animal models for infectious
disease and novel treatments. To provide a comprehensive resource, a committee of
experts chose 13 primate species. Tissues samples were then taken from 21 tissues
and next-generation sequencing of RNA (RNA-seq) was performed using three dif-
ferent approaches. The result was 40.5 billion 100 nucleotide reads that needed to
be assembled into transcriptomes for each species and RNA-seq method used (13
species× 3 methods= 39 assemblies). Because most of these species do not have any
reference genome, the transcriptomes must be assembled de novo. The details behind
the motivation for this resource and the generation of the RNA-seq data are described
in detail in the NHPRTR paper[10].
3.2.3 Enabling large-scale de novo transcriptome assembly with
Trinity on Blacklight
As described in the NHPRTR paper, investigators found that assembling the nearly
2 billion reads required as input for these de novo transcriptome assemblies was
beyond the capabilities of their local systems and even beyond the capacity of the
program’s initial estimates of large data inputs. At this point, they applied for an
XSEDE allocation on Blacklight at the PSC, along with Extended Collaborative Support
Services (ECSS) from XSEDE to help them perform these transcriptome assemblies of
unprecedented size and scale using Trinity [4]. Through XSEDE’s ECSS, PSC worked
closely with the Trinity developers to harden Trinity on Blacklight and find the best
way to run these massive assemblies.
To begin, PSC installed the latest, optimized version of Trinity contributed by the
National Center for Genome Analysis Support (NCGAS) at IU, without which these
assemblies would have taken several times longer to complete [11]. Even with this
optimized version, challenges appeared immediately. While Blacklight had plenty of
shared memory to handle the assemblies, at one point in the assembly, the Chrysalis
phase [4], Trinity was creating and working on hundreds of thousands of files. Even
very large assemblies of say, 600 million reads, while still producing tens of thousands
of files, had no problem executing on the default Lustre filesystem, but the 2 billion
read assemblies being attempted here produced too many files to be handled efficiently
Building primate annotations de novo and their processing 45
1.8	  Billion	  RNA-­‐seq	  reads	  from	  one	  primate	  species	  (~320GB)	  
•  Remove	  adapters	  
•  Quality	  ﬁlter	  
•  Remove	  Poly	  A/T	  
•  Remove	  mtDNA,	  rRNA	  
•  Convert	  to	  fasta	  
(performed	  in-­‐house)	  
~1.4	  Billion	  RNA-­‐seq	  reads	  (~200GB)	  
Inchworm	  
Typical	  Run	  Ome:	  100	  hours	  
Cores	  needed:	  64	  
Chrysalis	  (Run	  on	  RAM	  disk)	  
Typical	  Run	  Ome:	  400	  hours	  
Cores	  needed:	  128	  cores	  
QuanOfy	  Graph	  &	  BuUerﬂy	  (Run	  on	  RAM	  disk)	  
Typical	  run	  Ome:	  50	  hours	  
Cores	  needed:	  64	  cores	  
Figure 3.3: Walltime and core counts for various stages of the Trinity pipeline to assemble a
single primate transcriptome. See Reference [4] for descriptions of the phases of
Trinity.
by this filesystem. To work around this, PSC established a local filesystem attached
directly to Blacklight. This alleviated the problem for a single massive Trinity assembly,
but I/O-related slowdowns occurred with many massive assemblies running at once.
Finally, an ideal workflow was devised (Figure 3.3), utilizing Blacklight’s RAM
disk at the right points in the workflow to speed up the calculations, run many
assemblies at once, and avoid problematic I/O issues but also avoid wastefully using
RAM disk for large files where it was less beneficial. First, preprocessing of the data,
a primarily serial task, was performed on the research group’s local resources. The
preprocessed data were then moved to Blacklight’s Lustre filesystem, and the initial
Inchworm stage of the assembly was performed entirely on the Lustre filesystem using
64 cores. For the Chrysalis stage, we introduced a modification to the Trinity code
that allowed the Chrysalis directory to be given a different path from the rest of the
Trinity working directory. This allowed the Chrysalis files to be created on RAM disk,
while large files that did not need RAM disk remained on the Lustre filesystem. This
phase generally required 128 cores (1 TB RAM) to provide extra memory resources
to store files on the RAM disk associated with the job. After the Chrysalis phase was
complete, the job script would back up the Chrysalis directory to the Lustre filesystem
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but then continue to operate on those files in RAM disk for the final QuantifyGraph
and Butterfly stages of Trinity. We found that using 64 threads on 64 cores for the
QuantifyGraph and Butterfly stages and running from RAM disk provided optimal
performance, reduces the runtime of those steps from a total of 250 h (when running
from Lustre using 32 threads) to 50 h. Even after these optimizations, a significant
amount of resources were needed, with a typical de novo assembly for one primate
species with ~1.8 billion RNA-seq reads taking around 550 compute hours using
64-128 cores (35,200-70,400 service units). This de novo assembly method has proven
successful, generating transcriptomes with a mean average size >2 kb for most RNA-
seq methods used. Out of the 39 total assemblies required, 20 of the largest assemblies
were performed on Blacklight over a period of a few weeks Table 3.2.
3.2.4 Characterizing the de novo assembled transcriptomes
In order to evaluate the accuracy of the de novo transcriptome assemblies, we
determined the percentage that our assembly reconstituted the publicly available
genome annotations (Table 3.3). Currently, only five NHP species from our data set
have reference genomes: chimpanzee (panTro4), gorilla (gorGor3), rhesus macaque
(rheMac3), marmoset (calJac3), and mouse lemur (micMur1). For species without
reference genomes, we mapped to the nearest genome. For the gene models, we used
annotations that were generated from native mRNA (RefSeq) and annotations that
were computationally predicted (ENSEMBL). In most cases, the genes were either
assembled >80% of their gene model or not assembled at all. In every NHP species
with a reference genome, there was an improvement in assembling RefSeq genes
compared with assembling ENSEMBL gene predictions. Most notably, we were able
to recover >90% of RefSeq genes in rhesus macaque. The lack of coverage of genes
in mouse lemur may represent the incompleteness of the draft genome, which lies
entirely in scaffolds. The ability of Trinity to recover most of the known gene models
shows that the de novo assemblies built for NHP species without a reference genome
are good representations of the actual annotations. Because many studies are designed
to be dependent on certain reference genomes, we provide transcriptome assemblies
for many additional NHP species without reference genomes and also show that it is
possible to accurately rebuild any species’ transcriptome with high-coverage RNA-seq
data. In addition to the known genes that were built by Trinity, we were interested in
the assembled transcripts that were not currently annotated. We looked for evidence
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Table 3.3: Percentage of known (RefSeq) and predicted genes (ENSEMBL) covered by de novo
assembled transcriptomes.
Species
(genome)
RefSeq genes
covered >80%
Percentage of all
RefSeq genes
ENSEMBL gene
predictions covered
>80%
Percentage of all
ENSEMBL gene
predictions
Chimpanzee
(panTro4)
1,888 77% 18,928 68%
Gorilla
(gorGor3)
N/A N/A 17,142 59%
Rhesus Macaque
(rheMac3)
5,519 91% 14,290 57%
Marmoset
(calJac3)
124 73% 18,247 56%
Mouse Lemur
(micMur1)
N/A N/A 3,693 15%
Figure 3.4: Putative novel noncoding RNA gene in chimpanzee on chromosome 13. This
putative gene overlaps an exon from human long intergenic noncoding RNA gene
457.
of novel putative noncoding RNAs by filtering the assemblies for sequences that
were in the current annotation and/or contained open reading frames that were
90 bp or longer. Noncoding RNA genes are RNA molecules that are transcribed
but are not translated into proteins. Noncoding RNA genes have been implicated
in many biological roles ranging from necessary components of protein translation
(transfer RNAs) to major effectors of X inactivation (Xist) [12]. The abundance of long
noncoding RNAs in NHP genomes remains unclear. In chimpanzee, we identified 4489
possible novel noncoding RNAs. Figure 3.4 shows a putative novel noncoding RNA
in chimpanzee that contains an exon from a human long intergenic non-protein coding
RNA (LINC RNA), LINC00457. LINC00457 is primarily expressed in the human brain
http://www.ebi.ac.uk/arrayexpress/browse.html?keywords=E-MTAB-513.
3.2.5 Hosting a community resource
Now that the initial set of the massive de novo assemblies have been completed, the
finished transcriptomes are being hosted on storage resources at the PSC so that the
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community of researchers interested in these data can apply for an XSEDE allocation
and use Blacklight or other XSEDE resources to further work with and analyze the
data. The researchers working with NHPRTR are planning additional assemblies
and cross-transcriptome alignments, for which the ready availability of these data
on XSEDE will be most useful [10]. Lastly, because they have been encouraged by
these results, the NHPRTR group of researchers has started a larger set of brain and
region-specific deep RNA-sequencing of the 21 tissues across all the primates, which
will create an additional 11 billion reads and an expanded resource for research in
the NHPs, including evolutionary models, improved genome annotation across all
primates (humans included), and improved models for infectious disease like HIV
(using SIV) and AIDS.
3.2.6 Rapid Algorithm Development
One of the potential advantages of Blacklight’s massive shared memory architec-
ture is to enable scientists and developers to quickly prototype new parallel solutions
to their research problems. As a simple example, when working with very large
genomic data sets or other very large volume data, researchers often encounter cir-
cumstances where a heterogeneous group of large memory commands need to be
executed expeditiously. While working with Trinity on Blacklight, a researcher and
Trinity developer was able to quickly design a program to efficiently execute parallel
commands that require large amounts of shared memory during the QuantifyGraph
and Butterfly stages of Trinity. This program, Parafly, uses C++ and OpenMP to launch
a large set of jobs with varying memory requirements, filling the need for a versatile
parallel execution program within Trinity. Parafly accepts a flat file with the group
of commands that a user wishes to execute for input, placing minimal requirements
on the end user for operation. The program operates by loading all commands to be
executed into an array data structure, assigning thread conditions to each command
to be executed, then executes each command in parallel while logging the exit status
of each command. Parafly was incorporated into the main Trinity code, and since then
has been spun off as a separate project and extended to efficiently execute any group
of tasks that require a large amount of shared memory per system thread. The Parafly
resource can be found for download at http://parafly.sourceforge.net/.
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3.2.7 Conclusion
Results have been presented comprising for high-throughput, high-memory as-
semblies of 20 primate transcriptomes. These advances are breaking new ground in
their respective fields, and some, like the metagenome assembly and development of
the NHPRTR would have been extremely difficult or impossible to do on any other
system. While these diverse accomplishments highlight the power and flexibility of
Blacklight’s architecture for the assembly of NGS data, the research community is still
becoming aware of these capabilities. As a result, Blacklight’s potential to assemble
the largest single organism genomes, or even larger metagenomic samples, has not yet
been fully tested. As more groups engage with researchers who have benefitted from
this resource, and engage with XSEDE through its ECSS and novel and innovative
project programs, we expect demand to continue to grow, along with our ability to
harness the full potential of available NGS data to solve the most challenging problems
in computational biology.
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3.3 Recent Assemblies
Since we saw a linear relationship in the number of input sequences used and
the quality of the transcripts produced (Figure 3.2), we decided to pool both Phase
I RNA-Seq data (presented in Chapter 2) and tissue-specific Phase II RNA-Seq data
[13] to create a better transcriptome assembly. In addition to this, in order to have
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an equivalent transcriptome assembly in humans, we decided to use GTEx RNA-Seq
data [14] for tissues that were matched to the NHPRTR tissues to create a de novo
assembly for humans. Table 3.4 shows the summary statistics for the most recent
assemblies with human and marmoset. Surprisingly, we were able to assemble the
human de novo assemblies with GTEx RNA-Seq data with relative ease. In fact, one
of our assemblies completed in only 9 days. The reason why the human assemblies
finished so quickly is unclear. Typically, we perform a step-wise construction of the
assemblies by separating the job into the four phases of Trinity (Inchworm, Chrysalis,
QuantifyGraph, and Butterfly), and at the end of each phase, recursively copy back all
of the millions of files produced in case the algorithm fails at any point or if the system
fails at any point. The human assemblies did not require a step-wise construction,
and ran as one single job. The human assemblies generated with >5 billion RNA-
Seq reads (~2 billion reads greater than any other de novo assembly that we have
attempted) but the data was unstranded paired-end 76bp while the NHPRTR data was
stranded paired-end 100bp. We speculate that the read-length could make a difference
in causing more complexity in the de Bruijn graphs, which might increase the run-time.
In fact, we have attempted to create new assemblies using NHPRTR Phase I and
NHPRTR Phase II data for almost all species, but currently we have only been able
to complete two of these assemblies, chimpanzee and marmoset. The non-human
primate assemblies are extremely difficult to complete although the exact reasons are
unclear. Typically, our non-human primate assemblies require at least 1.5 months for
completion if the job does not fail at some point (either system failure or algorithm
failure). All non-human primate jobs have failed at some point in time because of
system failure and/or algorithm failure.
3.4 Primate RNA-Seq Resources
On our private instance of the UCSC genome browser mirror, we have hosted all
tissue-specific bigwigs and Trinity assembly annotation tracks aligned to their nearest
genome. Table 3.5 describes the genomes that are supported and the tissues that have
bigwig tracks. For assemblies that are not yet available on UCSC (baboon-papAnu3,
mouse lemur-micMur3, sooty mangabey-cerAty1), we have created track assembly
hubs for viewing assemblies and tissue-specific data.
1from Brawand et al. (2011)[15]
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Table 3.5: Genomes supported with Trinity assembly and RNA-Seq bigwig tracks.
Species Genome Assemblies
available
Tissues in bigwig tracks
Human hg38 2xGTEx
assemblies
cerebellum, colon, frontal cortex,
pituitary gland, heart, lymphnode,
kidney, liver, lung, muscle, spleen,
whole blood
Human hg19 None cerebellum, colon, frontal cortex,
pituitary gland, heart, lymphnode,
kidney, liver, lung, muscle, spleen,
whole blood
Chimpanzee panTro5 Phase I +
Phase II
polyA
bone marrow, cerebellum, colon,
frontal cortex, temporal lobe, pitu-
itary gland, heart, lymphnode kid-
ney, liver, lung, muscle, spleen, thy-
mus
Chimpanzee panTro4 Phase I+II
polyA, Phase
I polyA,
normalized
Phase I+II
polyA
bone marrow, cerebellum, colon,
frontal cortex, temporal lobe, pitu-
itary gland, heart, lymphnode kid-
ney, liver, lung, muscle, spleen, thy-
mus
Gorilla gorGor3 Phase I polyA frontal cortex, cerebellum, heart,
kidney, liver, testis1
Cynomolgus
Chinese
macFas5,
rheMac3
Phase I polyA
(mRNA stan-
dard and
mRNA with
UDG)
cerebellum, frontal cortex, pituitary
gland, colon, kidney, liver, lung,
lymphnode, spleen, thymus
Cynomolgus
Mauritian
macFas5,
rheMac3
Phase I polyA cerebellum, frontal cortex, pituitary
gland, temporal lobe, colon, heart,
kidney, liver, lung, lymphnode,
muscle, spleen, thymus
Pig-tailed
Macaque
macNem1,
rheMac3
Phase I polyA bone marrow, cerebellum, pituitary
gland, temporal lobe, colon, heart,
kidney, liver, lung, lymphnode,
muscle, spleen, thymus
Rhesus
Macaque
Indonesian
rheMac3 Phase I polyA none
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Table 3.6: Genomes supported with Trinity assembly and RNA-Seq bigwig tracks (continued).
Species Genome Assemblies
available
Tissues in bigwig tracks
Rhesus
Macaque
Chinese
rheMac3 Phase I polyA none
Japanese
Macaque
Indonesian
rheMac8,
rheMac3
Phase I polyA
(mRNA stan-
dard)
bone marrow, cerebellum, frontal
cortex, pituitary gland, colon, heart,
kidney, liver, lung, lymphnode,
muscle, spleen, thymus
Sooty
Mangabey
cerAty1,
rheMac8,
rheMac3
Phase I polyA bone marrow, cerebellum, pituitary
gland, colon, heart, kidney, liver,
lung, lymphnode, muscle, spleen,
thymus
Baboon papAnu2,
papAnu3
Phase I poly
A
bone marrow, cerebellum, pituitary
gland, temporal lobe, colon, heart,
kidney, liver, lung, lymphnode,
muscle, spleen, thymus
Marmoset calJac3 Phase I+II
polyA, Phase
I polyA,
Phase I total
RNA
bone marrow, left brain, right brain,
pituitary gland, colon, heart, kid-
ney, liver, lung, lymphnode, spleen
Squirrel Mon-
key
saiBol1 none bone marrow, cerebellum, frontal
cortex, pituitary gland, temporal
lobe, colon, heart, kidney, liver,
lung, lymphnode, muscle, spleen
Mouse
Lemur
micMur2,
micMur3
Phase I polyA cerebellum, frontal cortex, tempo-
ral lobe, colon, kidney, liver, lung,
muscle, spleen
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Chapter 4
Alternative splicing expansion in
humans
This next chapter describes unpublished material from recent work. It describes
the development of a cross-primate skipped exon database solely based on de novo
annotation, and displays the strength of using a de novo transcriptome assembly
approach in analyzing poorly or even unannotated genomes.
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Abstract
We present the first study to systematically identify and measure
alternative splicing directly across species with relying on annota-
tion. Additionally, we performed the most comprehensive analysis
of alternative splicing across primates to date. We identified 14,201
one-to-one orthologous skipped-exon events that relied only on de
novo assembly of RNA-Seq data from human, chimpanzee, baboon,
and cynomolgus macaque. We measured percent-spliced-in (Ψ) in
each of these events in each tissue from each species. Ψ can be inter-
preted as the frequency in which the cassette exon is included in the
final transcript. We find that the alternative splicing has been increas-
ing in primates leading to humans with greater relative abundance
of alternative splicing events. We show that the fastest increasing
abundance of alternative splicing occurs in cerebellum and heart. We
show that the cerebellum has a large amount of differentiation that
is driven by its low variance within humans, and show that there is
an excess of high Ψ values in this tissue. We show that low Ψ values
are propagating in tissues such as lung and spleen that have low dif-
ferentiation. Additionally, we find that humans display more gains
and fewer losses of alternative splicing in every tissue. We show that
alternative splicing displays different amounts of conservation in dif-
ferent tissue. Specifically, the core splicing pattern in muscle, heart,
and brain are conserved across primates whereas all other tissues
are lineage-specific. Brain tissues show accelerated change compared
to other tissues and we show that alternative splicing changes in
the brain are more predictive of selection based on the variance in
conservation scores at different levels of Ψ.
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4.1 Introduction
The differential inclusion and exclusion of exonic sequences generated by alterna-
tive splicing (AS) is one of the main sources for expanding the number of proteins
that can be produced by a single gene. As sequencing has increased in humans, the
number of genes that encode more than one mRNA has also increased. Although
it had been thought that AS was relatively rare when it was discovered, it is now
widely accepted that > 95% of human genes are alternatively spliced. The evolu-
tionary implications of expanded proteomic diversity remain unclear. AS provides
a high level of evolutionary plasticity, and it is often speculated that changes in AS
that are not conserved might underlie phenotypic variations between species and
between individuals within species [1]. Recent examples in species-specific adap-
tations have provided support for this claim [2]. Because even point mutations in
exons and introns can enhance or disrupt splicing control elements, it is thought that
splicing patterns are constantly evolving. However, opposing viewpoints regarding
the evolution of AS in tissues and the abundance of AS in primates still exist [3, 4]. In
one specific but important example of the opposing viewpoints, Merkin et al. (2012)
[4] show that brain, heart, and muscle AS patterns are conserved across mammals
while Barbosa-Morais et al. (2012) [3] showed that all tissues had species-specific AS
patterns. We sought to clarify this and many other unresolved questions on the evo-
lution of AS in primates and provide new insight into the importance of AS in humans.
4.2 Methods
We identified AS events using the 8 non-human primate de novo transcriptome
assemblies described in Chapter 3. We attempted to re-assemble most transcripts
using both NHPRTR Phase I (pooled RNA-Seq data) [5] and Phase II (tissue-specific
RNA-Seq data) [6] because we have found that increasing the amount of input RNA-
Seq reads to be assembled de novo greatly improved the quantity and accuracy of the
assembled transcripts. However, because of technical artifacts that were inherent in
our RNA-Seq data, we were only reliably able to create skipped exon annotations
from the transcriptome assembly. Additionally, we created an equivalent human de
novo transcriptome assembly using tissue-matched RNA-seq data provided by the
GTEx consortium [7], and used the same method described in Chapter 3. No other
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Figure 4.1: Example of a skipped exon event identified from Marmoset de novo transcriptome
assembly using our method.
annotation was used for our analysis and all annotations (including human) were
derived directly from RNA-seq data. Out of the four basic types of alternative splicing
(alternative 5’ splice-site selection, alternative 3’ splice-site selection, cassette-exon
inclusion or skipping, and intron retention), because of the intronic contamination
that was present in the RNA-seq data (and carried over to the de novo assemblies),
we filtered for high confidence exon-skipping events from the de novo assemblies.
Exon-skipping gradually increases further up the mammalian tree and exon-skipping
is the most prevalent type of AS in mammals. Out of all types of AS events conserved
between human and mouse, 38.4% are exon-skipping events [8]. We identified exon-
skipping events in each de novo assembly as an event where a cassette exon was present
in between two of the same exons, and two isoforms (one with the cassette exon, one
without the cassette exon, and identified by their unique ID assigned by Trinity) were
fully assembled (Figure 4.1). Additionally, we only identified events that preserved
strand in the exon-skipping structure (both within the exons and introns). We aligned
all de novo assemblies using a derivation of STAR [9], STARlong, which is an alignment
program specifically designed to align fully assembled transcripts to genomes. The
STARlong alignment specifications that we used for human genome build hg38 were
the following:
STARlong --genomeDir hg38 --readFilesIn Trinity.fasta
--outFilterMismatchNmax 5000 --outFilterMismatchNoverLmax 0.05
--sjdbOverhang 100 --seedPerReadNmax 50000
After alignments, strand for the transcripts was assigned directly from the strand-
specific RNA-Seq raw reads where at least 90% of the raw reads were of the same
strand. Since GTEx RNA-Seq was unstranded, strand assignments of skipped exon
events from GTEx data was inferred from at least 90% overlap with the latest gencode
annotations (version 26). Table 4.1 describes the number of skipped-exon events
identified from the de novo assemblies. We have found that de novo assemblies created
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Table 4.1: Number of Splicing Events Identified
Species Genome # of Skipped
Exon Events
Identified
Data used for as-
sembly
Human hg38 15,956 61 GTEx samples
Chimpanzee panTro5 7,290 NHPRTR Phase I
and II
Baboon papAnu2 3,277 NHPRTR Phase I
Cynomolgus
Macaque
macFas5 5,203 NHPRTR Phase
I (Mauritian
and Indonesian
subspecies)
Japanese Macaque
Indonesian
rheMac8 3,161 NHPRTR Phase I
Sooty Mangabey cerAty11 6,141 NHPRTR Phase I
Pig-tailed
Macaque
macNem1 6,064 NHPRTR Phase I
Marmoset calJac3 226 NHPRTR Phase I
calJac3 2,600 NHPRTR Phase I
and II
Mouse Lemur micMur2 6,799 NHPRTR Phase I
micMur3 7,008 NHPRTR Phase I
Alternative splicing expansion in humans 62
from more reads (~5 billion reads, when combining the Phase I and II data, as opposed
to ~3 billion reads, when using Phase I data only) allowed us to identify more events.
Even though ideally we would like to use de novo assemblies built from combined
Phase I and II data only, many of our assemblies ran into complications during the
build with the Trinity software we were not able to finish these jobs in time for this
dissertation. The number of exon skipping events identified are not an accurate
measure of the actual number of exon-skipping events present in the genome because
they also depend on the number of reads used for the de novo assembly, the tissues
used in the assembly (in some species we had missing tissues), and differences in the
build quality produced by Trinity. We have found that Trinity has produced different
transcriptomes of varying quality (measured against gencode annotation) from the
same input dataset. Notice that using only NHPRTR Phase I data for marmoset only
yielded 226 splicing events but when we ran the assembly another time using both
NHPRTR Phase I and Phase II data we identified >10× splicing events. Since we
did not rely on any existing gene annotation, we were able to reliably identify exon-
skipping events even in cases where the genomes were unannotated or had limited
annotation. A custom skipped exon annotation was created for each primate genome
build. We used UCSC reciprocal best chain files with liftOver for the latest genome
builds for each primate species to map one-to-one orthologous events. For orthologous
mapping of skipped exon events, flanking constitutive exons were matched by at least
90% of each exon. We used the STAR software (version 2.5.2b) with RNA-seq short-
read specifications to align all of the tissue-specific RNA-seq reads to their own genome
except in the case of the species Japanese Macaque (Indonesian) where only the nearest
genome for Rhesus Macaque, rheMac8, was available. We identified 14, 201 one-to-one
orthologous exon skipping events that preserved the same structure and strand as
pictured in Figure 4.1 across human, chimpanzee, baboon, and cynomolgus macaque.
We then used the software Mixture of Isoforms probablistic model for RNA-Seq (MISO)
[10] to calculate percent-spliced-in (Ψ) in each exon-skipping event in each tissue using
custom annotation created for each exon-skipping event identified from our de novo
assemblies. MISO uses Bayesian inference to calculate the probability that an observed
read was produced from an isoform which is specified by the annotation. Since we
are calculating Ψ using an exon-centric analysis (as opposed to an isoform-centric
analysis), the Ψ values calculated can be easily interpreted as the frequency in which
the cassette exon is spliced-in in all isoforms of that gene. A Ψ of 1 is interpreted as a
constitutive exon whereas a Ψ of 0 is interpreted as an exon that is never spliced-in.
1Unannotated genome.
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To standardize our Ψ calculations for different read lengths we took into account
the paired-end insert length size and standard deviations for each tissue-specific
RNA-Seq sample. We calculated gene expression read counts using Bioconductor
package easyRNASeq [11] with our custom skipped-exon annotation. To correct for
batch effects between samples we used Bioconductor package NOISeq [12]. Our
pseudogene skipped exon annotation set was manually curated from a mixture of
transcribed and processed pseudogenes identified by Gencode (version 26) [13] and
those exons that overlapped gencode pseudogene exons by 90%. The Ψ calculations for
pseudogenes were done with the same method as the skipped-exon events identified
from the assemblies. PhyloP scores [14] were taken from phyloP 7-way alignments
from hg38. The assemblies used in those alignments were human, chimpanzee, rhesus,
dog, mouse, rat, and opossum.
4.3 Results
4.3.1 Human cerebellum shows the most increase in AS abundance
in AS events
To estimate the abundance of AS events in tissue samples we used a measure of
relative AS abundance, which we define as the number of skipped exon events with a
Ψ value > 0.10 and < 0.9 normalized by the total read count of that tissue RNA-Seq
sample. Humans have an increased abundance in AS events at a similar rate for all
tissues compared to NHPs (Figure 4.2). Chimpanzees show an abundance of AS
events greater than macaques and baboons but less than humans for all tissues, which
is in contradiction to Barbosa-Morais et al. (2012) [3] who reported that chimpanzees
had greater AS abundance than humans for most tissues and except for cerebellum
which displayed an increase more than double of any other tissue. Cerebellum, spleen,
and colon displayed the most increase (β0 < −0.7) in relative AS abundance vs.
divergence time from human (Table 4.2).
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Table 4.2: Linear regression models of log(relative AS abundance) vs. divergence time (millions
of years ago) from human.
Tissue β0 β1 p− value
Cerebellum -0.7789087 10.76068 0.00602**
Frontal Cortex -0.4737367 10.566 0.0335*
Pituitary Gland -0.56529 10.82636 0.1002
Colon -0.7382033 10.8715 0.01145*
Heart -0.5768427 10.64198 0.0444*
Kidney -0.43059 10.55065 0.1006842
Liver -0.6620833 10.6155 0.0489*
Lung -0.6399217 10.7223 0.0899
Lymphnode -0.596945 10.67459 0.0784
Muscle -0.6290173 10.44821 0.0182*
Spleen -0.7784953 10.86707 0.0371*
Figure 4.2: Relative abundance of AS events in all tissues for humans and 4 NHPs (human,
chimpanzee, cynomolgus macaque chinese, cynomolgus macaque mauritian, and
baboon)in 11 tissues (cerebellum, frontal cortex, pituitary gland, colon, heart,
kidney, liver, lung, lymphnode, muscle, and spleen).
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Figure 4.3: Heatmap of Jenson-Shannon divergence (1 −
√
JSD) for read counts in exon-
skipping events (n = 14, 201) in humans and 4 NHPs (Chimpanzee, Baboon,
Cynomolgus Macaque Chinese, and Cynomolgus Macaque Mauritian). Tissues
used for organ systems: Cardiovascular (Heart, Blood), Lymphatic (Lymphnode),
Digestive (Colon, Liver), Endocrine (Pituitary Gland), Muscular (Skeletal Muscle),
Nervous (Cerebellum, Frontal Cortex, Temporal Lobe), Respiratory (Lung), Urinary
(Kidney), Immune (Spleen, Thymus). Clustering was performed using Euclidean
distance with complete linkage.
4.3.2 Brain, Heart, and Muscle have a conserved splicing pattern
Since tissues have a well-described tissue-dominated conserved gene expression
pattern across species, we clustered read counts calculated from our exon-skipping
annotation to check for data quality (Figure 4.3). Although a tissue-dominated
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Figure 4.4: Heatmap of Jenson-Shannon divergence (1−
√
JSD) for Ψ in exon-skipping events
(n = 14, 201) for humans and 4 NHPs (Chimpanzee, Baboon, Cynomolgus Macaque
Chinese, and Cynomolgus Macaque Mauritian). Tissues used for organ systems:
Cardiovascular (Heart, Blood), Lymphatic (Lymphnode), Digestive (Colon, Liver),
Endocrine (Pituitary Gland), Muscular (Skeletal Muscle), Nervous (Cerebellum,
Frontal Cortex, Temporal Lobe), Respiratory (Lung), Urinary (Kidney), Immune
(Spleen, Thymus). Clustering was performed using Euclidean distance with com-
plete linkage.
clustering is apparent in our data for gene expression, the clustering of Ψ shows a
species-specific dominated clustering for most tissues except for brain, heart, and
muscle (Figure 4.4). This provides more evidence for the brain, heart, and muscle
conserved splicing pattern observed in mammals by Merkin et al. (2012) [4] which
used only 489 splicing events but disagrees with the species-dominated splicing
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pattern reported in humans and NHPs by Barbosa-Morais et al. (2012) [3]. It is
apparent in the clustering with Ψ that certain tissues show a species-specific pattern
faster than others. Even though cynomolgus macaque Mauritian and cynomolgus
macaque Chinese show a similar splicing pattern for all tissues, they diverge patterns
in two tissues involved in immune response (spleen and thymus). Additionally,
although the divergence time between macaques and baboons (6-8 million years ago)
is similar to the divergence time between chimpanzees and humans (6 million years
ago), humans and chimpanzees show no conservation in splicing patterns except for
tissues conserved in mammals (brain, heart, and muscle). On the other hand, baboons
and macaques display a similarity for almost all other non-conserved tissues (except
those involved in immune response). A closer look at the clustering ofΨ values in brain
tissues reveal that although the overall splicing pattern is more conserved than other
tissues, a species-dominated clustering is observed within brain tissues (Figure 4.5).
Additionally, two distinct clusters form when k = 2 during hierarchical clustering
between humans and NHPs. Since Ψ is a quantitative trait, we calculated QST for Ψ
values. QST is an FST -like measure for the amount of differentiation for quantitative
traits. Specifically, where "pibetween" is defined as the amount of variance between the
two groups (humans and non-human primates), vB, and "piwithin" is defined as the
amount of variance within each group, vW . We calculated QST for 10 tissues (Table
4.3). Cerebellum, kidney, and liver show the greatest amount of differentiation, but
the cerebellum QST measure is driven by the least amount of within group variance.
Muscle shows the least amount of differentiation with the lowest amount between
group variance.
4.3.3 Cerebellum shows an excess of high Ψ values.
We have found that not all tissues evolve at the same rate. By comparing the bulk
distributions of Ψ across tissues, we have found that some tissues such as spleen, colon,
and lung show an excess of low Ψ values whereas cerebellum shows an excess of high
Ψ values (Figure 4.6; Mann-Whitney, p-value=5.817x10−13). The tissues that display
a tissue-dominated clustering such as spleen, lung, and lymphnode also display an
excess of low Ψ values. For example, lung compared to muscle shows an excess of low
Ψ values (Figure 4.7; Mann-Whitney, p-value=3.832x10−10). Cerebellum is the only
tissue that shows an excess of high Ψ values.
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Figure 4.5: Heatmap of Jenson-Shannon Divergence (1−
√
JSD) for Ψ in exon skipping events
(n = 14, 201) in brain tissues (cerebellum, frontal cortex, and temporal lobe) for hu-
mans and 4 NHPs (chimpanzees, baboon, cynomolgus macaque chinese, cynomol-
gus macaque mauritian). Clustering was performed using Euclidean distance with
complete linkage.
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Table 4.3: QST measurements between humans and non-human primates for differentiation
in Ψ values for 10 tissues. vB is the amount of variance between the two groups
(humans and non-human primates) and vW is the amount of variance within each
group.
Tissue QST vB vW
Kidney 0.04155683 0.01062531 0.1225281
Liver 0.03331782 0.008369649 0.1214184
Cerebellum 0.02116257 0.005071102 0.1172775
Frontal Cortex 0.01541406 0.003782551 0.1208068
Pituitary Gland 0.01334571 0.003117966 0.1152563
Heart 0.0132788 0.003330524 0.1237423
Spleen 0.01251225 0.003084136 0.1217025
Colon 0.008418166 0.002076753 0.1223111
Lung 0.007827337 0.001947248 0.123414
Muscle 0.005002717 0.00124231 0.1235423
Figure 4.6: Empirical cdf plot of cerebellum and lung.
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Figure 4.7: Empirical cdf plot of muscle and lung.
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Figure 4.8: Sashimi plot in liver for a pseudogene example: zinc finger protein 37B, pseudogene
(ZNF37BP, ENSG00000234420).
4.3.4 Skipped-exon events in pseudogenes are conserved in brain
We curated a set of skipped-exon events in known human transcribed and pro-
cessed pseudogenes to serve as a neutrally evolving dataset in which to compare
our skipped-exon dataset identified from genes. Many pseudogenes show a non-
conserved pattern in both expression and Ψ values in the same tissue (Figure 4.8). In
one example from the zinc finger protein 37B pseudogene, Ψ can range from 0.17 to
0.61 in the same human tissue. But upon looking at the overall splicing pattern in all
human tissues, a conservation of Ψ values in brain was observed (Figure 4.9)
4.3.5 Differences in conservation scores surrounding skipped-exon
in different tissues
We calculated the mean conservation scores (phyloP) 60bp upstream and down-
stream of the skipped exon as well as 25bp within the skipped exon. The meta plot
of these mean phyloP scores surrounding skipped exon events reveal a difference
in conservation between high Ψ values (Ψ>0.9) and low Ψ values (Ψ<0.1) (Mann-
Whitney Ψ<0.1 vs. Ψ>0.9 p-value=0.04903; Mann-Whitney 0.45>=Ψ<=0.55 vs. Ψ>0.9
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Figure 4.9: Heatmap of Jenson-Shannon Divergence (1−
√
JSD) for Ψ in exon skipping events
in human pseudogenes. Tissues used for organ systems: Cardiovascular (Heart,
Blood), Lymphatic (Lymphnode), Digestive (Colon, Liver), Endocrine (Pituitary
Gland), Muscular (Skeletal Muscle), Nervous (Cerebellum, Frontal Cortex, Tem-
poral Lobe), Respiratory (Lung), Urinary (Kidney), Immune (Spleen, Thymus).
Clustering was performed using Euclidean distance with complete linkage.
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Figure 4.10: Meta plot of mean phyloP conservation scores (mean± SEM) in human cerebellum
surrounding skipped exon events (60bp upstream of the exon, 25bp into the exon
for both exon boundaries, and 60bp downstream of the exon) at different Ψ values
(Ψ > 0.9,Ψ >= 0.45andΨ <= 0.55, and Ψ < 0.1).
p-value=0.04171; Mann-Whitney 0.45>=Ψ<=0.55 vs. Ψ<0.1 p-value=0.1681; Figure
4.10). For high Ψ values, there is less conservation in the bases in the flanking introns
and high conservation at the splice-site and within the exon. For low Ψ values, the
opposite is observed, there is less conservation at the splice-sites and within the exon
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Figure 4.11: Mean± SEM phyloP conservation scores at high Ψ values (Ψ > 0.9) surrounding
skipped exons (60bp upstream of the exon, 25bp into the exon for both exon bound-
aries, and 60bp downstream of the exon) for cerebellum, lymphnode, muscle, and
spleen.
but greater conservation in the flanking introns. There is also more conservation in the
upstream intron than the downstream intron at all Ψ values. These observations are
consistent with the known importance of GT-AG splice site recognition in constitutive
exons, and the observations that alternative exons depend more on splice control
elements (enhancers and silencers) for the alternative exon to be recognized by the
splicing machinery and that the control elements upstream of the exon may be more
important for exon recognition. The conservation scores surrounding skipped exon
at high Ψ (Ψ > 0.9) are similar for all tissues (Figure 4.11, Mann-Whitney test not
significant). However, for low Ψ values (Ψ < 0.1), there is a significant difference
between brain tissues and other tissues in conservation scores within and surround-
ing skipped exons (Figure 4.12, Mann-Whitney test between cerebellum and muscle
p-value=3.71x10−4, Mann-Whitney test between cerebellum and frontal cortex not
significant, and Mann-Whitney test between muscle and spleen not significant).
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Figure 4.12: Mean± SEM phyloP conservation scores at low Ψ values (Ψ < 0.1) surrounding
skipped exons (60bp upstream of the exon, 25bp into the exon for both exon
boundaries, and 60bp downstream of the exon) for cerebellum, frontal cortex,
spleen, and heart.
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Figure 4.13: Gains and losses of AS events (line plot) for 11 tissues (cerebellum, frontal cortex,
pituitary gland, colon, heart, kidney, liver, lung, lymphnode, muscle, and spleen)
and their mean tissue specificity (bar plot). All gained AS events (both line and
bar plot) are in red and all lost AS events (both line and bar plot) are in blue.
B=baboon, M=cynomolgus macaque, C=chimpanzee, H=human.
4.3.6 Humans have fewer loss of AS events and more gain of AS
events in all tissues.
We analyzed the frequency of AS events gained and lost in 11 tissues and their
mean tissue specificity (Figure 4.13). We defined an AS event gained as Ψ <= 0.9 in 1
species with all other species having a Ψ value of Ψ >= 0.95. We defined an AS event
lost as Ψ >= 0.95 in 1 species with all other species having a Ψ value of Ψ <= 0.9. We
used a measure of mean tissue specificity described by Yanai et al. (2004) [15]. All
tissues (except for lymphnode) show an increase in AS events gained in humans with
kidney, cerebellum, and frontal cortex gaining the most AS events. AS events that
were lost tended to have greater tissue specificity than AS events that were lost in all
species. Skeletal muscle showed the least changes in AS events gained or lost across
species. Additionally, tissues that had high QST values such as cerebellum and kidney
also had more gains and less loss of AS events while tissues that had low QST values
such as muscle also had fewer changes in AS events. Surprisingly, both baboon and
macaques displayed only a limited amount of AS events gained (all tissues for baboon
and macaque had fewer than 15 gained events). AS events that were lost in humans
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Figure 4.14: Mean phyloP conservation profile for AS events lost in human compared to all
AS events of high Ψ.
show a significantly lower profile in conservation surrounding the skipped exon than
AS events that share the same high level of Ψ values (Ψ >= 0.95; Figure 4.14);
4.4 Discussion
We present the most comprehensive evolutionary analysis of alternative splicing
in mammals to date. By not relying on existing annotation and generating custom
annotations directly for each species and for each of the tissues we had RNA-Seq
data for, we were able to generate an orthologous splicing database that was almost
30× the scope of previous analyses [4]. The results provide overwhelming support
to show that not all tissues evolve through AS at a similar rate. Even though it was
hypothesized in 2012 that AS evolves at rate two- or three- times faster than gene
expression, it has been inconclusive whether AS truly species-specific or if AS is con-
served in certain tissues in mammals. From our clustering (Figure 4.4), QST (Table
4.3), and AS gains and losses (Figure 4.13) analyses, it is apparent that skeletal muscle
is the most conserved tissue in terms of AS. Skeletal muscle exhibits both a tissue-
dominated clustering as well as the lowest QST , and the fewest AS gains and losses
out of all of the tissues studied. Muscle also does not display an excess of low Ψ
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values in its distribution. As for the faster evolving tissues, lymphnode, spleen, and
thymus are the first tissues to exhibit a species-specific clustering and all show an
excess of low Ψ values in their distributions. Furthermore, at high Ψ values (Ψ>0.9),
these tissues have significantly lower mean conservation scores than muscle at high Ψ
values (Figure 4.11). Since lymphnode, spleen, and thymus are all part of the immune
system, the faster change in Ψ values might be a reflection of the important role AS
plays in species-specific immunity against pathogens. Although brain tissues show a
tissue-dominated clustering pattern, there are many important distinctions from other
tissues that exhibit the same pattern (i.e., muscle). The tissue-dominated clustering
pattern might be more of a reflection of the importance of a conserved core set of
genes to exhibit such a pattern. Specifically, Figure 4.10 does not show a significant
difference in mean conservation scores surrounding the skipped exon between high Ψ
values (Ψ>0.9) and intermediate Ψ values in cerebellum. Brain tissues also show the
greatest range in mean conservation scores surrounding the skipped exon. At high
Ψ values (Ψ>0.9), cerebellum and frontal cortex exhibit similar mean conservation
scores but at low Ψ values (Ψ<0.1), their scores are significantly lower than any other
tissues. This diverse range in conservation scores (as opposed to spleen) might mean
that AS in brain is more predictive of selection. This notion along with the increas-
ing abundance and differentiation of AS events in human brain (and in cerebellum
especially) provide good evidence that this expansion of AS events could explain part
of the phenotypic complexity exhibited between humans and non-human primates.
Furthermore, cerebellum is the only tissue that exhibits an excess of higher Ψ values in
its distribution. Although we attempted to use pseudogenes as a neutral evolutionary
dataset in which to estimate the rate of AS change in tissues, we surprisingly observed
a conservation of AS of pseudogenes in brain. Additionally, we saw an elevation
of mean conservation scores within the skipped exon of pseudogenes compared to
the surrounding introns. Since processed pseudogenes were not randomly spliced
as expected, this could be evidence of a functional role for pseudogenes in the brain.
Additionally, it is especially remarkable that baboons and macaques both show such
few gains of alternative splicing events, which might be representative of the increased
reliance of alternative splicing going towards the human lineage as a mechanism to
generate new isoforms.
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4.5 Concluding Remarks
Alternative splicing has been long proposed to underlie species-specific morpho-
logical adaptations in mammals because a small change in the DNA could give rise to
novel combinations of existing genes. However, to date, only a handful of examples
have been shown to support this theory. Similarly, studies analyzing the changes in
the DNA underlying novel phenotypes between humans and chimpanzees has also
only been shown for limited examples. This is the largest and most comprehensive
study for analyzing alternative splicing in primates, and we have provided more
evidence to support previous reports of splicing conservation in brain and muscle and
have disputed other reports that all tissues show lineage-specific splicing patterns.
Although it is unknown whether AS expansion reflects a functional expansion of the
transcriptome, we provide systematic evidence that AS provides a large source of
diversity that ultimately could underlie the observed phenotypic diversity between
humans and non-human primates. In the following chapter, we go into detail about a
few of the specific examples of changes that we have found in humans.
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Chapter 5
Human-Specific Alternative Splicing
This next chapter describes unpublished material from recent work. It describes the
human-specific alternative splicing events identified by the skipped-exon database de-
scribed in Chapter 4 through the use of Distributions of Isoforms in Single Cell Omics
(DISCO) which was developed by Mason lab member and fellow Tri-Institutional
Computational Biology and Medicine student Priyanka Vijay.
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Abstract
We present the first study to systematically identify human-specific
isoforms. We sought to identify the human-specific alternative splic-
ing events that are significantly different between humans and non-
human primates. We used the skipped-exon database of 14,201 one-
to-one orthologous alternative splicing events in human, chimpanzee,
baboon, and cynomolgus macaque described in Chapter 4. We
identified 3,954 significant differential splicing events in 1,807 genes.
Heart and cerebellum showed the most significant changes between
humans and non-human primates. We identified the underlying
causes that might explain some of our top differential splicing results:
IFI16, MLH3, HERC2P2, and LRRC75A-AS1, a highly expressed sno-
lncRNA. We show that small changes in the DNA can cause large
changes in isoforms to the point where exons are either completely
gained or completely lost. Our GO analyses show that the human-
specific splicing events are enriched for pathways and biological func-
tions involving morphogenesis and immune functions. We reveal that
GO analyses of the top differential splicing results are important in
many highly conserved pathways. Our top GO canonical pathway
in every tissue was integrin signaling, which is a main contributer of
morphogenesis. Additionally, GO analysis of significantly different
splicing brain tissues are involved in morphological adaptations and
development of the central nervous system, and heart is enriched for
the morphogenesis and development of the heart.
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5.1 Introduction
The rapid recent accumulation of genomic, transcriptomic, and proteomic data
has led to a wealth of resources to allow for the study of the molecular characteristics
that could best explain the observed phenotypic differences between species. A large
part of the evidence for the basis of organismal complexity in the primate lineage
leading to humans is still missing. In Chapter 4, we described a database that used
transcriptomic data to allow for the analysis of alternative splicing changes across
primate species. We were interested to identify specific examples that are present
in the overall splicing pattern changes and to see whether they reveal insight into
whether or not they might underlie morphological adaptations. To date, only a
handful of examples of human-specific isoforms have been described and most are
not identified with a systematic approach. By utilizing our skipped exon database, we
were able to show that the differences in alternative splicing in humans is enriched
for morphogenesis and development of highly species-specific tissues such as brain
and muscle. Additionally, our top differentially spliced genes could all be accounted
for by changes in the DNA surrounding or directly adjacent to the splice sites which
either hindered or enhanced splicing of the alternative exon. All of our differential
splicing results presented here show a "switch-like" effect where an exon is completely
spliced-in or completely spliced-out.
5.2 Methods
We used the skipped-exon splicing database described in Chapter 4. We used
Distributions of Isoforms in Single Cell Omics (DISCO) to identify the significantly
different splicing between humans and non-human primates in each skipped exon
event for 10 tissues (cerebellum, frontal cortex, colon, heart, kidney, liver, lung, muscle,
pituitary gland, and spleen). DISCO uses non-parametric statistical testing with
multiple testing correction to test differences in isoform abundance relative to all
isoforms specified by annotation supplied to MISO [1]. We identified 3,954 total
significant differential splicing events in 1,807 genes using the t-test with significance
level q− value < 0.05. Splicing control element motifs were identified with human
splicing finder 3.0 [2]. We used dbSNP to identify polymorphic mutations in humans.
Gene ontology analysis was performed with Ingenuity Pathway Analysis (IPA) version
36601845 Software (Ingenuity Systems, Redwood City, CA, USA; www.ingenuity.com).
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We assigned genes to our custom splicing events if they overlapped our event by at
least 95%. 13 of the significantly different splicing events could not be assigned to
known genes. We used dbSNP to identify polymorphisms in our genes of interest
[3]. Ortholog sequences for multiple alignments were downloaded from ENSEMBL,
t-Coffee was used for the multiple alignment, and PAML was used to calculate dN/dS
ratios. Human variation analyses were performed with 1000 Genomes Phase III data.
Extended haplotype homozygosity analysis was performed using Selscan.
5.3 Results
The significant differential splicing results using DISCO are described in Table 5.1.
Cerebellum, heart, and frontal cortex showed the most significant changes in splicing.
Table 5.1: DISCO significant results (Humans vs. Non-Human Primates).
Tissue Number of signifi-
cant genes
Number of genes
expressed
(# of significant
genes)/(# of genes
expressed)
Heart 950 11,155 0.0851636
Cerebellum 594 11,057 0.05372162
Frontal Cortex 472 11,576 0.04077402
Pituitary Gland 445 11,786 0.03775666
Spleen 313 10,372 0.0301774
Kidney 297 11,099 0.02675917
Muscle 241 9,572 0.0251776
Colon 238 11,620 0.020418193
Liver 216 8,914 0.0243155
Lung 188 12,069 0.0155771
We identified the top 10 differentially spliced genes in all tissues in Table 5.2. Many
of our top results were significant in multiple tissues. The low p-values in heart are a
reflection of the conservation of splicing in that tissue and because we had double the
number of human samples for that tissue to include in the analysis.
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Figure 5.1: Sashimi plot for exons 6, 7, and 8 in IFI16 in spleen for six species. All species used
their latest genome build while Sooty Mangabey and Japanese Macaque Indonesian
RNA-Seq reads were aligned to rheMac8.
5.3.1 Gene duplication within IFI16 creates a human-specific exon.
Our top differentially spliced gene was IFI16 (in heart, p-value=9.023x10−16). It
was also significantly differentially spliced in cerebellum, frontal cortex, pituitary
gland, colon, kidney, liver, lung, muscle, and spleen. Sashimi plots of spleen revealed
that non-human primates are missing an exon upstream of the alternatively spliced
exon, and include the alternative exon in most transcripts (Figure 5.1). All species
that have a greater divergence time from human than chimpanzee almost always
splice-in the alternative exon (0.99 >= Ψ <= 1), while chimpanzee has a decreased
Ψ value of 0.79. Marmoset, squirrel monkey, and mouse lemur also show high
values of Ψ (Ψ > 0.95) in all tissues (not shown). IFI16 encodes a nucleic acid sensor
that is essential for directly or indirectly mediating the responses against viruses and
bacteria. It plays a central role in the immune response to herpesviruses. Previous
studies have shown that IFI16 carries a polymorphic segmental duplication of exon
7 (Figure 5.2; [4]). Exon 7 carries a 56-amino acid motif which encodes the central
"hinge" domain of the molecule. The exon 7 duplication results in differing the size
of the hinge domain, which separates two conserved copies of the hematopoietic
interferon-inducible protein (HIN-200) domains [5]. Differential splicing of IFI16 in
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Figure 5.2: Humans carry a polymorphic segmental duplication of exon 7 in IFI16.
humans has been shown to generate three protein isoforms from exon 7 which either
result in exon 7 being completely spliced-out or one or both copies of exon 7 being
spliced-in [5]. Furthermore, Johnstone et al. (1998) [6] reported that the addition of
the hinge region changes the functional properties of IFI16 and its ability to act as
a transcriptional repressor. They speculated that the three splice variants possibly
change the conformation of the molecule, and it has also been observed that the three
isoforms have different functional properties [7]. The exon 7 segmental duplication
is polymorphic in humans and has been reported as a risk variant for celiac disease
and rheumatoid arthritis [8]. Additionally, Kimkong et al. (2009) [9] observed an
upregulation of the isoform that results from one copy of exon 7 being spliced-in in
the inflammatory disease systemic lupus erythematosus. Interestingly, Cagliani et al.
(2014) [4] reported the presence of a duplicated exon 7 in gorilla and orangutan but
single copies of exon 7 in chimpanzees, cynomolgus macaque, and vervet. Numerous
studies have reported that IFI16 is under strong positive selection [4, 10]. Even though
there are low and high levels of nucleotide diversity throughout IFI16, the duplicated
exon 7 is flanked by low levels of nucleotide diversity (Figure 5.3). Cagliani et al.
(2014) have reported that IFI16 is under positive selection in primates, but they observe
that the exon 7 segmental duplication is neutrally evolving or is subject to recent or
weak selection. We sampled a SNP from the duplicated exon (rs199769901) to test
for recent positive selection using 1000 genomes data. We observed a strong signal
of positive selection from a preservation of the extended haplotype homozygosity
(Figure 5.4).
5.3.2 Significant change in MLH3, a member of a conserved family
of genes involved in the mismatch repair system
Mutant L homolog 3 (MLH3) is a member of a family of evolutionarily conserved
proteins that has roles in both DNA mismatch repair and meiosis. MLH3 has been
proposed to be involved in the repair of insertion-deletion errors at microsatellite
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duplicated exon 7 in humans
Figure 5.3: Nucleotide diversity in IFI16. Red boxes are locations of exons.
repeat sequences [11]. MLH3-deficient mice result in meiotic arrest and aneuploidy
[12]. Additionally, mismatch repair genes have been postulated to play a role in
human fertility both through spermatogenesis and female infertility. Polymorphisms
in this gene have been associated with an increased risk for female infertility [13]. We
observed a significant difference in Ψ in humans for exon 3 of MLH3 in cerebellum,
frontal cortex, pituitary gland, colon, heart, kidney, liver, lung, muscle, and spleen
(Figure 5.5). Kansal et al. (2015) [14], identified an infant with MLH3 variants (one
heterozygous missense mutation in exon 3) which displayed severe developmental
delay along with many tumors in the cerebellum, brainstem, lumbar spine, and in
additional tissues. Multiple alignments with 17 primates near the 5’ end of the skipped
exon revealed 3 fixed human-specific mutations (dbSNP reveals no polymorphisms
identified) within 25bp of the splice site. A search for intronic splicing elements in
non-human primates revealed that one of the fixed mutations falls within a motif
of a binding site for splicing silencer hnRNP A1 (Score of 97.14/100; Figure 5.6).
The disruption of an hnRNP A1 binding site in such proximity to the splice site
as well as the other fixed changes in an otherwise highly conserved region might
be responsible for the dramatic change observed for exon 3 inclusion of this gene
in humans. Since MLH3 plays such an important role in fundamental biological
processes, it is surprising that we observe this change in exon inclusion in humans in
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Figure 5.4: Extended Haplotype Homozygosity (EHH) plot of rs199769901.
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Figure 5.5: Sashimi plot for MLH3 in pituitary gland.
Figure 5.6: Multiple alignment with 17 primates for 5’ region of alternative exon for MLH3.
Red box indicates where the splicing control element binding site motif was identi-
fied.
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skipped in non-human primates
Figure 5.7: Nucleotide diversity in MLH3.
every tissue tested. We also observed a dN/dS ratio of 0.5628 in the coding region of
MLH3 using multiple alignments of MLH3 with human and 7 non-human primates
(orangutan, marmoset, mouse lemur, gibbon, chimpanzee, rhesus macaque, and
baboon). Weis et al. (2008) analyzed evolution of MLH3 found an iHS <2, dN/dS
of 0.6 in the ORF, sequence divergence of 1.0, 1.7, 1.6, and 2.1 in the 3’UTR, 5’UTR,
promoter, and introns, respectively. We also found a dN/dS ratio of 0.5628 in MLH3
using 8 primates. Although dN/dS ratios are low within this gene, the skipped exon
is in a region of very low polymorphism (Figure 5.7). Humans have a specific set
of disease susceptibilities compared to other species. In particular, because of the
environment of the modern lifestyle and the extension of life expectancy in humans,
humans are more susceptible to obesity, diabetes, cardiovascular disease, cancer, and
neurodegenerative disease. Humans have a particularly high rate of spontaneous
neoplasms, and this could be attributed to differences in the human cellular response
to DNA damage.
5.3.3 The birth of a new human exon: HERC2P2
The hect domain and RLD 2 pseudogene 2 (HERC2P2) is highly expressed in all
tissues and during human fetal brain development tissues (Brainspan data). It is one
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Figure 5.8: Sashimi plot of HERC2P2 for 11 species in cerebellum.
Figure 5.9: Multiple alignment of HERC2P2 for 17 primate species. Red box indicates the
location of the 5’ splice site creation.
of the few transcribed and processed pseudogenes that has a conserved expression
pattern in primates. Even though HERC2P2 is named a pseudogene, it has been
functionally validated as a lncRNA [17]. We found that it exhibited one of the strongest
shifts in Ψ when testing for differential splicing (Figure 5.8). The inclusion of the
skipped exon was significantly different in cerebellum, frontal cortex, pituitary gland,
colon, heart, kidney, liver, lung, muscle, and spleen. All tissues showed a high
inclusion of the exon (Ψ > 0.75). None of the non-human primates showed expression
at this skipped exon. The multiple alignment of 17 primates revealed three fixed
nucleotide changes at the 5’ end of HERC2P2 to create a new splicing site (Figure
5.9). The fitCons integrated signal score for the fraction of sites under selection
was 0.29 in the skipped exon indicating that the pseudogene has functional potential
[15]. Furthermore, the skipped exon is in a region of very low heterozygosity further
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New exon in humans
Figure 5.10: Low level of polymophisms within 1kb of alternative exon of HERC2P2.
indicating that this is in a conserved region (Figure 5.10). The deletion of HERC2P2
has been implicated in many neuropsychiatric and developmental disorders such
as Prader-Willi/Angelman Syndrome, schizophrenia and Autism spectrum disorder.
HERC2P2 is contained in a well described microdeletion of 15q11 that has also been
detected in behavioral and learning problems as well as neurological syndromes
such as epilepsy or spastic paraplegia. It has been hypothesized that this 15q11
region is functionally related to the nervous system [16]. Additionally, our analysis
from Chapter 4 indicated that transcribed and processed pseudogenes have higher
conservation in brain tissues. It was also upregulated in transcriptional profiling of
myocyte enhancer factor 2 (MEF2), a transcription factor that is highly expressed
in brain and is fundamental for neuronal survival and synaptic plasticity, in neural
progenitor cells [18]. Interestingly, HERC2P2 was one of the most significant genes out
of >47,000 genes tested that displayed modulation to exposure to a electromagnetic
field in human epidermal keratinocytes [19].
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Figure 5.11: Sashimi plot of the 4 isoforms in LRRC75A-AS1 in frontal cortex for humans (red)
and chimpanzee (orange).
5.3.4 Significant decrease in inclusion of exon in lncRNA
LRRC75A-AS1.
We observed a highly significant decrease in Ψ in humans in the highly expressed
lncRNA, LRRC75A-AS1. LRRC75A-AS1 is a host gene for two snoRNAs, SNORD49A
and SNORD49B, that alter the 5’ inclusion of exon 3 to produce 4 different isoforms.
All 4 isoforms show significantly different exon inclusion measures between humans
and non-human primates (Figure 5.11). The inclusion of exon 3 was significantly
decreased in human cerebellum, frontal cortex, pituitary gland, colon, heart, kidney,
lung, muscle, and spleen. Exon 3 overlaps with SNORD49B (Figure 5.12). A
fixed difference adjacent to the 5’ splice site in humans creates a putative hnRNP A1
binding site (score of 74.05) was also observed. hnRNP A1 is an inhibitor of splice
site recognition. Additionally, the integrated fitCons score for the alternative exon is
0.12324 indicating that a fraction of the sites are under selection, and LINSIGHT scores
were high in the snoRNAs. LRRC75A-AS1 is located in a region that is amplified in
human high grade osteosarcomas and has been shown to be significantly upregulated
in patients with rheumatoid arthritis and in triple negative breast cancer tissues
[20–22]. It is also a parent gene for a specific class of intron-derived lncRNAs (sno-
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Figure 5.12: The different isoforms of LRRC75A-AS1 as a consequence of SNORD49B and
SNORD49A and LINSIGHT scores. Yellow indicates location of snoRNAs.
lncRNAs) that depend on snoRNA machinery at both ends for their processing. No
sno-lncRNAs have been identified in mouse, and only 19 sno-lncRNAs have been
identified in the human genome [23]. Furthermore Zhang et al. (2014) [23] have found
that emergence of sno-lncRNAs is often co-encoded with the alternative splicing of
their host genes which leads to a species-specific expression. We observe this lineage-
specific change between humans and NHPs. Lykke-Andersen et al. (2014) [24] have
validated that the 5’ splice site of the skipped exon generates 4 alternative 3’ splice
sites that effect the expression of two snoRNAs, SNORD49B and SNORD49A. Since
the inclusion/exclusion of the skipped exon is extremely different in humans, this
difference in alternative splicing is potentially causing differences in the expression of
these snoRNAs.
5.3.5 Gene ontology enrichment in differentially spliced genes
We performed a gene ontology (GO) enrichment analysis of the genes that showed
significantly different splicing between humans and non-human primates. We ana-
lyzed each tissue separately for their enrichment of biofunctions (Figure 5.13). A
majority of the tissues (except tissues that we identified to be more differentiated in
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Figure 5.13: Heatmap of enriched biofunctions for significantly different splicing. log(p-values)
had a threshold of 6 and were normalized.
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Figure 5.14: Heatmap of enriched biological functions for significantly different splicing in
cerebellum and frontal cortex. log(p-values) had a threshold of 1.2 and were
normalized.
Chapter 4: colon, spleen, and lung) showed an enrichment for many highly conserved
functions like the organization of the cytoplasm and cytoskeleton, formation of cilia,
and microtubule dynamics. Furthermore, even in such a splicing conserved tissue as
muscle, there was an enrichment for biological functions involved in the aggregation
of myoblasts and the formation of muscle. Biological functions in the heart had a
surprising number of biological functions related to the morphogenesis of the heart,
specifically, morphology of the heart, QT interval of the heart, and morphology of
cardiac muscle. The GO enrichment analysis in cerebellum and frontal cortex also
showed enrichment for morphological biological functions related to those tissues
(Figure 5.14). Along with the biological functions also enriched in other tissues,
brain tissues show an enrichment of biofunctions directly related to their formation
such as morphology of nervous system, morphology of brain, and formation of brain.
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Figure 5.15: Heatmap of enriched pathways for differential splicing results.
Both cerebellum and frontal cortex are enriched for formation of cilia, which play an
important role in neurogenesis, and neural migration and differentiation. GO pathway
analysis revealed many highly conserved signaling pathways (Figure 5.15). Our
most significant canonical pathway, which was significant in every tissue, integrin
signaling, is a surprising result. Integrins are cell surface glycoproteins involved
in cell-cell interactions and cell-extracellular matrix interactions. Integrin-mediated
signaling has evolved and expanded for 1.5 billion years as the number of interactions
has increased due to such processes like gene duplication and alternative splicing
that has allowed for integrin-mediated specificity as the developmental complexity of
organisms has increased. Integrins contribute to the majority of morphogenetic events
that in a developing, multicellular organism [25, 26]. The phospholipase C pathway
has also been associated with evolutionary alterations of nucleosome affinities to core
promoters in the evolutionary lineage [27]. It is a key signal transduction pathway
involved in many sensory stimuli. Given the significant loss of olfactory receptors in
humans, changes in this pathway could be related [28]. Also surprising is the signifi-
cance of enrichment of neuronal nitric oxide synthase (nNOS) signaling in neurons in
cerebellum tissue. nNOS is a key regulator of affective behavior, and increasing nNOS
in brain has resulted in anxiety even in conditions where the environment is enriched
[29].
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5.4 Concluding remarks
The number of differences in splicing that we observed in muscle and frontal
cortex is consistent with differences observed in human muscle and frontal cortex
metabolomes [30]. Bozek et al. (2014) observed that the metabolite divergence in
human muscle and frontal cortex was much higher than any other tissues, and they
posited that it might be a reflection of the specialized endurance capacity of the
cardiovascular system and might account for the complexity of the brain. It is not
surprising that many of our top differentially spliced genes impact almost all of the
tissues that we analyzed. In our specific examples, we have identified mutations that
have become fixed in humans, and have either destroyed or created new splice sites or
binding sites for splicing control elements. At least two of our top differentially spliced
genes have been potentially impacted by hnRNP A1s which have been described
as the "Swiss Army knife" of gene expression [31]. Interestingly, in the case of our
identification of a new exon emerging in HERC2P2, we observed that Denisovans do
not have all of the fixed nucleotide changes that humans have [32]. All of our results
seem to be human-specific, and many are in highly conserved genes that are highly
expressed in most tissues. It is possible that these switch-like AS events in pivotal
genes that we have identified may play a role in rewiring entire programs of gene
regulation that can impact the observed differences between humans and NHPs. We
welcome further experimental validation, functional interpretation, and regulatory
studies from our outcome of our differentially spliced events analysis.
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Conclusion
“Evolution can seek new solutions without destroying the old. . . the extra
material is scattered in the genome, to be called into action at any time”
— Walter Gilbert, Why genes in pieces?, Nature 1978
Out of over 200 primates currently existing on earth today, in an evolutionary blink of
the eye humans have become the most dominant, adapting to all climates and even
changing the environment in a potentially irreversible way. Since the first comparative
genomics study by King and Wilson over 40 years ago, researchers have been search-
ing for the missing genetic basis of the origins of human traits. Humans are different
from other great apes by many biological characteristics (bipedalism, brain size, hair-
lessness, opposable thumbs, adolescence, gestation time) and many behavioral traits
(tool-making, language, social grouping, and symbolic thought), yet still only a few
specific examples (like human-specific Siglec genes and FOXP2) that underlie these
characteristics have been identified. Many expected that the sequencing of the human
and chimpanzee genomes would reveal these differences. Similarly, many expected
that comparing gene expression data through microarrays and now RNA-Seq would
reveal these differences. Yet, sequencing of the chimpanzee genome revealed that
the two genomes only differed by 1.2% in mostly non-coding DNA and compara-
tive gene expression studies revealed that tissue gene expression is highly conserved
even across as much as 300 million years. Although many important and compelling
human-specific discoveries have been made (for example loss of olfactory receptors,
loss of androgen receptor enhancers and changes in KITLG pigmentation genes), there
remain many more questions than answers. Alternative splicing is an ideal candi-
date that has the ability to create these differences. In fact, for most tissues, overall
splicing patterns are species-specific (Figure 4.4). Because of short-read sequencing
technology and poor annotation in non-human primates, the ability to comparatively
study differences in isoforms, has been inherently difficult. With short-read technology,
the accuracy in which to assign abundance to actual longer full-length isoforms (not
exons) remains extremely poor if not impossible. Only longer and more accurate
sequencing reads can solve this problem. The obstacles in data processing, annotation
creation, identifying skipped exon events, and orthologous database creation in this
project should not be overlooked. However, being able to finally find and study these
splicing differences in humans and non-human primates has been rewarding. In this
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Figure 5.16: A new human-specific gene discovered by de novo assembly.
thesis, we present a methodology that can systematically study alternative splicing
comparatively and our results show that splicing can indeed produce the diversity
that can account for the specialized human adaptations. Functionally proving what
each of these splicing changes do will be much more difficult. Currently, the vast
majority of alternative splicing events have not been functionally characterized on
any level. The future of the study of alternative splicing will be in the integration of
systems-level approaches to predict "the splicing code" more accurately. These studies
will be empowered by incorporating regulatory networks of multiple splicing factors,
epigenetic influences, the epitranscriptome, and the kinetics of splicing. In addition to
studying the comparative splicing of genes, we have observed many different species-
specific highly expressed genes that have yet to be characterized. Figure 5.16 shows
just one example of a human gene that we assembled that is not present in any current
annotation and is highly expressed in many different tissues, and is not present in any
of our non-human primate assemblies. We have not yet characterized all of the genes
even in the best annotated mammalian genome, ours. This just shows the extent to
which the complexity of the human genome still needs to be explored.
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